<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0084">
    <title>67 Rickettsia and Orientia</title>
    <sect1 id="ch0084s0001">
      <title>67 Rickettsia and Orientia</title>
      <anchor id="ch0084s0001a0001"/>
      <anchor id="ch0084s0000a0001"/>
      <para role="chapterAuthor"><phrase role="center">LUCAS S. BLANTON, DAVID H. WALKER, AND DONALD H. BOUYER</phrase>
      </para>
      <sect2 id="ch0084s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0084s0001a0002"/>
        <anchor id="ch0084s0000a0002"/>
        <para id="ch0084s0000p0001">The family<emphasis>Rickettsiaceae</emphasis> comprises two genera of small, obligately intracellular bacteria that reside free within the host cell’s cytosol, namely, <emphasis>Rickettsia</emphasis> and <emphasis>Orientia.</emphasis> Although the number and diversity of pathogenic strains in each genus are similar, the practices of species designation differ remarkably. The second edition of <emphasis>Bergey’s Manual of Systematic Bacteriology</emphasis> lists 20 validated names of <emphasis>Rickettsia</emphasis> species, and others have been proposed (<link linkend="ch0084s0000li0001">1</link>). Strains of <emphasis>Orientia tsutsugamushi</emphasis> have 0.8% divergence of the 16S rRNA gene. Similarly, other obligately intracellular bacteria have 0.5% 16S rRNA gene divergence within a species (e.g., <emphasis>Ehrlichia chaffeensis, Coxiella burnetii</emphasis>, and <emphasis>Chlamydia trachomatis</emphasis>). The genus <emphasis>Rickettsia</emphasis> has a disproportionate number of designated species (especially within the spotted fever group) relative to the genetic divergence of the bacteria (<link linkend="ch0084s0000li0002">2</link>, <link linkend="ch0084s0000li0003">3</link>). The criteria for the basis for these numerous species do little to aid clinical reasoning or understanding the diseases.</para>
        <para id="ch0084s0000p0002">The genus<emphasis>Rickettsia</emphasis> is divided by phylogenetic clustering into the typhus group (TG) and spotted fever group (SFG), defined originally by their distinctive lipopolysaccharide antigens, and the transitional and other ancestral groups that are widely distributed in arthropods (<link linkend="ch0084s0000li0004">4</link>). The TG consists of only two members, <emphasis>Rickettsia prowazekii</emphasis> and <emphasis>R. typhi</emphasis>, whereas the SFG contains several bacteria that are generally recognized as human pathogens (<emphasis>R. rickettsii, R. conorii, R. africae, R. sibirica, R. japonica, R. honei, R. parkeri, R. massiliae, R. monacensis, R. slovaca, R. aeschlimannii, R. raoultii</emphasis>, and <emphasis>R. helvetica</emphasis>), as well as others that have been identified only in arthropods (<link linkend="ch0084s0000li0001">1</link>, <link linkend="ch0084s0000li0004">4</link>, <link linkend="ch0084s0000li0005">5</link>). The transitional group, a clade between the TG and SFG, contains the pathogens <emphasis>R. akari, R. australis</emphasis>, and <emphasis>R. felis</emphasis> (<link linkend="ch0084s0000li0006">6</link>). Most <emphasis>Rickettsia</emphasis> spp. of undetermined pathogenicity, including <emphasis>R. amblyommatis, R. montanensis, R. bellii, R. peacockii</emphasis>, and <emphasis>R. rhipicephali</emphasis>, are more prevalent in U.S. ticks than is pathogenic <emphasis>R. rickettsii.</emphasis> SFG isolates originally identified in Israel and the Astrakhan region of Russia, which have wider geographic distributions, are genetic variants of <emphasis>R. conorii</emphasis>.</para>
        <para id="ch0084s0000p0003"><emphasis>O. tsutsugamushi</emphasis>, which was once considered to be a single-species genus, diverges from <emphasis>Rickettsia</emphasis> by approximately 10% in the 16S rRNA gene and differs in its cell wall structure, containing completely unrelated proteins and lacking lipopolysaccharide (<anchor id="ch0084s0000a0003"/><link linkend="ch0084s0000a0008">Table 1</link>). Phylogeny based upon <emphasis>groEL</emphasis>, a member of the molecular chaperone family, reveals genetic diversity for the genus <emphasis>Orientia</emphasis> similar to that for SFG <emphasis>Rickettsia</emphasis> spp. (<anchor id="ch0084s0000a0004"/><link linkend="ch0084s0000a0011">Fig. 1</link>) (<link linkend="ch0084s0000li0007">7</link>, <link linkend="ch0084s0000li0008">8</link>). <emphasis>O. tsutsugamushi</emphasis>, originally classified serologically, has subsequently been analyzed genetically. In individual geographic areas, there are several genetic variants. Phylogeny reveals nine clusters that are not identical with serotypes. The genotypes do not have strong evidence of geographic differentiation (<link linkend="ch0084s0000li0009">9</link>). Genetic variants of <emphasis>O. tsutsugamushi</emphasis> appear to correspond to particular arthropod hosts in which divergence most likely occurred. There have been changes in the genus <emphasis>Orientia</emphasis> with the addition of new candidate species. <emphasis>Orientia chuto</emphasis> sp. nov. was isolated from a patient infected in Dubai (<link linkend="ch0084s0000li0010">10</link>). This isolate has 98.5% homology to the 16S rRNA gene of <emphasis>O. tsutsugamushi</emphasis> strains Ikeda, Kato, and Karp and only 84.1 to 84.6% identity to the 47-kDa-protein gene (<emphasis>htrA</emphasis>) (<link linkend="ch0084s0000li0010">10</link>, <link linkend="ch0084s0000li0011">11</link>). There is also genetic evidence of another member of the genus in Chile, “<emphasis>Candidatus</emphasis> Orientia chiloensis.” Analysis of material from 18 patients demonstrated ≥99.7% homology for 16S rRNA gene and <emphasis>htrA</emphasis> among patient specimens. The agent responsible for scrub typhus in Chile is likely a separate <emphasis>Orientia</emphasis> species (<link linkend="ch0084s0000li0012">12</link>). Molecular methods have detected <emphasis>Orientia</emphasis>-like DNA (94.4 to 100% similarity by the 16S rRNA gene) from rodent spleens in Africa and Europe that clusters around <emphasis>Orientia chuto</emphasis> sp. nov. and a new basal group, respectively (<link linkend="ch0084s0000li0013">13</link>).</para>
      </sect2>
      <sect2 id="ch0084s0001s0002">
        <title>DESCRIPTION OF THE GENERA</title>
        <anchor id="ch0084s0001a0003"/>
        <anchor id="ch0084s0000a0005"/>
        <para id="ch0084s0000p0004">Species of<emphasis>Rickettsia</emphasis> are small (0.3 to 0.5 μm by 1 to 2 μm), obligately intracellular bacteria of the <emphasis>Alphaproteobacteria</emphasis> with a Gram-negative cell wall that contains lipopolysaccharide, peptidoglycan, a major 135-kDa S-layer protein (OmpB), a 17-kDa lipoprotein, and for SFG rickettsiae, a surface-exposed protein (OmpA) containing different numbers of nearly identical tandem repeat units (<link linkend="ch0084s0000li0014">14</link>). <emphasis>Rickettsia</emphasis> organisms have small (1.1- to 1.5-Mb), AT-rich genomes resulting from reductive evolution, with a high proportion (19 to 24%) of noncoding sequence. Among SFG and TG rickettsiae, the genomes have remarkable synteny (<link linkend="ch0084s0000li0015">15</link>). The lack of genes for enzymes for sugar metabolism, lipid biosynthesis, nucleotide synthesis, and amino acid synthesis and the presence of genes encoding enzymes for the complete tricarboxylic acid cycle and several copies of ATP/ADP translocase suggest both independent synthesis of ATP and acquisition of host ATP with rickettsial utilization of host sources for nutrition and building blocks. Rickettsiae adhere to the host cell receptor Ku70 by OmpB; by OmpA to an α<subscript>2</subscript>β<subscript>1</subscript> integrin receptor for SFG rickettsiae; by the β-peptide of OmpA to fibroblast growth factor receptor (<link linkend="ch0084s0000li0016">16</link>); and by Sca1 and Sca2 by unknown receptors. Attachment triggers host cell signaling pathways, leading to recruitment and activation of induced phagocytosis. Rickettsiae escape from the phagosome by membranolytic activities of rickettsial phospholipase D and TlyC (<link linkend="ch0084s0000li0017">17</link>–<link linkend="ch0084s0000li0019">19</link>). <emphasis>O. tsutsugamushi</emphasis> (0.3 to 0.5 μm by 0.8 to 1.5 μm) has a 2.1-Mb genome with high proportions of genes encoding mobile genetic elements, identical repeats, and fragmented genes and a low coding capacity (<link linkend="ch0084s0000li0020">20</link>). The organisms have a major surface protein of 54 to 58 kDa as well as 110-, 80-, 47-, 42-, 35-, 28-, and 25-kDa surface proteins and an atypical peptidoglycan, but lack lipopolysaccharide. Compared with <emphasis>Rickettsia</emphasis> spp., <emphasis>Orientia</emphasis> has a more plastic Gram-negative cell wall with a thicker outer leaflet and thinner inner leaflet of the outer envelope.</para>
        <anchor id="ch0084s0000a0006"/>
        <beginpage pagenum="1280"/>
        <anchor id="ch0084s0000a0007"/>
        <beginpage pagenum="1281"/>
        <table id="ch0084s0000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0084s0000a0008"/><link linkend="ch0084s0000a0003">TABLE 1</link></phrase></emphasis> Characteristics of <emphasis>Rickettsia</emphasis> spp. and <emphasis>O. tsutsugamushi</emphasis><superscript><emphasis><anchor id="ch0084s0000a0009"/><link linkend="ch0084s0000a0010">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="6">
            <tbody>
              <row>
                <entry><phrase role="left">Organism</phrase>
                </entry>
                <entry><phrase role="center">LPS</phrase>
                </entry>
                <entry><phrase role="center">OmpA</phrase>
                </entry>
                <entry><phrase role="center">OmpB</phrase>
                </entry>
                <entry><phrase role="center">17-kDa lipoprotein</phrase>
                </entry>
                <entry><phrase role="center">56-kDa protein</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">SFG</phrase>
                </entry>
                <entry><phrase role="center">S</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">TG</phrase>
                </entry>
                <entry><phrase role="center">T</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. canadensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">T</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. bellii</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">B</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>O. tsutsugamushi</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0084s0000a0010"/><link linkend="ch0084s0000a0009">a</link></emphasis></superscript>Abbreviations and symbols: LPS, lipopolysaccharide; S, SFG lipopolysaccharide present; T, TG lipopolysaccharide present; B, <emphasis>R. bellii</emphasis> type lipopolysaccharide present; +, present; 0, absent.</para>
        <figure id="ch0084s0000f0001"><title><phrase role="figureLabel"><anchor id="ch0084s0000a0011"/><link linkend="ch0084s0000a0004">FIGURE 1</link></phrase> Phylogeny of <emphasis>Rickettsia</emphasis> and <emphasis>Orientia</emphasis> as determined by unweighted maximum-parsimony analyses of <emphasis>groEL</emphasis> gene sequences, with <emphasis>Escherichia coli</emphasis> as the outgroup (prepared with PAUP 4.0 software). Numerical values on the branches represent the quantity of genetic divergence from the nearest node.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0084f03.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
      <sect2 id="ch0084s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0084s0001a0004"/>
        <anchor id="ch0084s0000a0012"/>
        <para id="ch0084s0000p0005">Pathogenic<emphasis>Rickettsia</emphasis> spp. reside in an arthropod host (tick, mite, louse, flea, or other insect) for at least a part of their life cycle, during which they are maintained by transovarian transmission and/or cycles involving horizontal transmission to vertebrate hosts (<link linkend="ch0084s0000li0021">21</link>–<link linkend="ch0084s0000li0024">24</link>) (<anchor id="ch0084s0000a0013"/><link linkend="ch0084s0000a0016">Table 2</link>). <emphasis>Orientia</emphasis> spp. are maintained in nature by transovarian transmission in trombiculid mites, which transmit infection to humans during larval stage feeding (<link linkend="ch0084s0000a0016">Table 2</link>).</para>
      </sect2>
      <sect2 id="ch0084s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0084s0001a0005"/>
        <anchor id="ch0084s0000a0014"/>
        <para id="ch0084s0000p0006">In addition to Rocky Mountain spotted fever (RMSF), rickettsialpox, murine typhus, flying squirrel-associated<emphasis>R. prowazekii</emphasis> infection, <emphasis>R. parkeri</emphasis> infection, and Pacific coast tick fever, which are indigenous to the United States, there is significant potential for travel-related cases of African tick bite fever, boutonneuse fever, murine typhus, and scrub typhus (<link linkend="ch0084s0000a0016">Table 2</link>) (<link linkend="ch0084s0000li0025">25</link>–<link linkend="ch0084s0000li0031">31</link>). Other rickettsioses, either because of their geographic distribution and the infrequency of travelers’ exposure to them or because of their incidence, are unlikely to be travel related. RMSF, louse-borne typhus, and scrub typhus are life-threatening illnesses even for young, previously healthy persons. Murine typhus and boutonneuse fever can have a fatal outcome in patients who are elderly or have underlying diseases or other risk factors. A study of 140 patients infected with <emphasis>R. conorii</emphasis> that were admitted to Portuguese hospitals indicated that alcoholism and infection with the Israeli strain are risk factors for a fatal outcome. Fatal cases more frequently have acute renal failure, hyperbilirubinemia, obtundation, tachypnea, petechial rash, gastrointestinal symptoms, and coagulopathy (<link linkend="ch0084s0000li0032">32</link>).</para>
        <para id="ch0084s0000p0007">An average of 7 days after tick bite inoculation of rickettsiae, patients with RMSF develop fever, severe headache, malaise, and myalgia, frequently accompanied by nausea, vomiting, and abdominal pain and sometimes cough (<link linkend="ch0084s0000li0027">27</link>). A rash typically appears only after 3 to 5 days of illness. Rickettsiae infect endothelial cells, frequently leading to increased vascular permeability and focal hemorrhages. In severe cases, noncardiogenic pulmonary edema may occur (<link linkend="ch0084s0000li0033">33</link>); development of encephalitis, coma, and seizures are grave conditions that cause long-term neurologic sequelae (<link linkend="ch0084s0000li0034">34</link>) and often presage death (<link linkend="ch0084s0000li0035">35</link>).</para>
        <para id="ch0084s0000p0008"><emphasis>R. parkeri</emphasis> causes a milder illness with tick inoculation site eschar, fever, headache, myalgia, usually a maculopapular or vesiculopapular rash, less frequently tender regional lymphadenitis, and no reported deaths (<link linkend="ch0084s0000li0036">36</link>). Rickettsialpox has been recognized mainly as a nonfatal urban disease with disseminated vesicular rash and an eschar at the location of rickettsial inoculation by the feeding mite (<link linkend="ch0084s0000li0028">28</link>). <emphasis>R. felis</emphasis> infection has been recognized as having a wide geographic distribution in accordance with the ubiquitous cat flea (<link linkend="ch0084s0000li0037">37</link>). Although some reported cases exhibit signs and symptoms similar to those of other rickettsioses (<link linkend="ch0084s0000li0038">38</link>), the significance of <emphasis>R. felis</emphasis> DNA circulating within the bloodstream of both febrile subjects and afebrile controls in sub-Saharan Africa is yet to be elucidated and has caused some to raise questions regarding the true pathogenic nature of the organism (<link linkend="ch0084s0000li0037">37</link>, <link linkend="ch0084s0000li0039">39</link>).</para>
        <para id="ch0084s0000p0009">Murine typhus causes a rash in approximately one-half of patients. Pulmonary manifestations (cough and chest radiographic infiltrates) and mild renal dysfunction occur in some patients. In a minority, severe illness with seizures, coma, renal failure, and respiratory failure occurs (<link linkend="ch0084s0000li0040">40</link>). Although the untreated case-fatality rate is low (0.4%) (<link linkend="ch0084s0000li0041">41</link>), illness can be protracted, and severe manifestations necessitate intensive care unit admission in 10% of hospitalized cases (<link linkend="ch0084s0000li0026">26</link>).</para>
        <para id="ch0084s0000p0010">Travelers who have returned from Africa and develop fever, one or more eschars, and in some cases regional lymphadenopathy and a maculopapular or vesicular rash are very likely infected with<emphasis>R. africae</emphasis> (<link linkend="ch0084s0000li0029">29</link>).</para>
        <para id="ch0084s0000p0011">Due to their small size, ability to be aerosolized, and low infectious dose,<emphasis>Rickettsia</emphasis> species pose a danger to laboratory staff and should be handled in biosafety level 3 (BSL-3) facilities. The most pathogenic rickettsiae, <emphasis>R. prowazekii, R. rickettsii, R. typhi</emphasis>, and <emphasis>R. conorii</emphasis>, are bioterrorism threats (<link linkend="ch0084s0000li0042">42</link>).</para>
        <para id="ch0084s0000p0012">Scrub typhus caused by<emphasis>O. tsutsugamushi</emphasis> occurs in the geographic area that is bordered by Korea and Russia on the north, Australia and Indonesia on the south, Pakistan and Afghanistan on the west, and Japan, the Philippines, and Micronesia on the east. Clinical signs and symptoms of the disease include fever, headache, maculopapular rash, eschar, interstitial pneumonia, temporary deafness, lymphadenopathy, and central nervous system involvement (<link linkend="ch0084s0000li0043">43</link>). The frequency of various manifestations may be strain dependent; the observed differences between <emphasis>O. tsutsugamushi</emphasis> organisms in the Boryong and Karp phylogenetic clades include differences in those with weakness (91% versus 61%), eschars (97% versus 74%), skin rashes (94% versus 68%), and conjunctival injection (45% versus 3%), occurring with increased frequency with organisms in the Boryong genotype (<link linkend="ch0084s0000li0044">44</link>). Without treatment, mortality can reach 30% (<link linkend="ch0084s0000li0045">45</link>). The index case of <emphasis>O. chuto</emphasis> spp. nov. and cases of “<emphasis>Candidatus</emphasis> Orientia chiloensis” are characterized by fever, inoculation eschar, rash, headache, myalgia, and lymphadenopathy (<link linkend="ch0084s0000li0010">10</link>, <link linkend="ch0084s0000li0046">46</link>).</para>
      </sect2>
      <sect2 id="ch0084s0001s0005">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0084s0001a0006"/>
        <anchor id="ch0084s0000a0015"/>
        <para id="ch0084s0000p0013">For the isolation of rickettsiae, blood should be collected as early as possible in the course of illness and obtained in a sterile heparin-containing vial prior to the administration of antimicrobial agents that are active against rickettsiae (<link linkend="ch0084s0000li0027">27</link>, <link linkend="ch0084s0000li0047">47</link>). For isolation, blood may be stored temporarily at 4°C and should be processed as promptly as possible. If inoculation of cell culture or animals must be delayed for more than 24 h, plasma, buffy coat, whole blood, or biopsied tissue should be frozen rapidly and stored at −70°C or in liquid nitrogen. EDTA- or sodium citrate-anticoagulated blood collected in the acute state has been used effectively for the diagnosis of boutonneuse fever, murine typhus, epidemic typhus, Japanese spotted fever, scrub typhus, and, with lower sensitivity, RMSF and African tick bite fever, by nucleic acid amplification testing (NAAT) (<link linkend="ch0084s0000li0029">29</link>, <link linkend="ch0084s0000li0047">47</link>–<link linkend="ch0084s0000li0051">51</link>). NAAT provides a higher diagnostic yield when applied to biopsy specimens of rickettsia-infected lesions, particularly eschars (<link linkend="ch0084s0000li0032">32</link>, <link linkend="ch0084s0000li0052">52</link>–<link linkend="ch0084s0000li0054">54</link>). If whole blood, plasma, buffy coat, or tissue cannot be processed for NAAT within several days, it should be stored at −20°C or lower. Serum has a lower sensitivity for NAAT but is often diagnostic in fatal cases (<link linkend="ch0084s0000li0055">55</link>, <link linkend="ch0084s0000li0056">56</link>). The DNA yield from eschar swabs collected for the NAAT detection of rickettsiae is adequate when swabs are stored for up to 72 h at 4°C. Collection involves using a sterile saline-dipped cotton swab vigorously rotated over an unroofed eschar (<link linkend="ch0084s0000li0057">57</link>).</para>
        <table id="ch0084s0000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0084s0000a0016"/><link linkend="ch0084s0000a0013">TABLE 2</link></phrase></emphasis> Etiology, epidemiology, and ecology of select rickettsial diseases
</title>
          
          <tgroup cols="5">
            <tbody>
              <row>
                <entry><phrase role="center">Organism</phrase>
                </entry>
                <entry><phrase role="center">Disease</phrase>
                </entry>
                <entry><phrase role="center">Geographic distribution</phrase>
                </entry>
                <entry><phrase role="center">Typical mode of transmission to humans</phrase>
                </entry>
                <entry><phrase role="center">Natural cycle</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">SFG</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. rickettsii</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">RMSF</phrase>
                </entry>
                <entry><phrase role="left">Western hemisphere</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks and vertebrate-tick cycles</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. conorii</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Boutonneuse fever</phrase>
                </entry>
                <entry><phrase role="left">Southern Europe, Africa, Middle East</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks and likely vertebrate-tick cycles</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. africae</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">African tick bite fever</phrase>
                </entry>
                <entry><phrase role="left">Sub-Saharan Africa, Caribbean</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. parkeri</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Maculatum disease</phrase>
                </entry>
                <entry><phrase role="left">North and South America</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. sibirica</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">North Asian tick typhus, lymphangitis-associated rickettsiosis</phrase>
                </entry>
                <entry><phrase role="left">Asia, Europe, Africa</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. japonica</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Japanese spotted fever</phrase>
                </entry>
                <entry><phrase role="left">Japan, Korea, China</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. heilongjiangensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Far Eastern tick-borne rickettsiosis</phrase>
                </entry>
                <entry><phrase role="left">Russia</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. honei</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Flinders Island spotted fever</phrase>
                </entry>
                <entry><phrase role="left">Australia, Thailand</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. slovaca</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Tick-borne lymphadenopathy</phrase>
                </entry>
                <entry><phrase role="left">Eurasia</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Unknown</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">TG</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. prowazekii</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Louse-borne typhus</phrase>
                </entry>
                <entry><phrase role="left">Worldwide</phrase>
                </entry>
                <entry><phrase role="left">Infected louse feces rubbed into broken skin or mucous membranes or inhaled as aerosol</phrase>
                </entry>
                <entry><phrase role="left">Human-louse cycle; flying squirrel-flea and/or -louse cycle</phrase>
                </entry>
              </row>
              <row>
                <entry/>
                <entry><phrase role="left">Brill-Zinsser disease</phrase>
                </entry>
                <entry><phrase role="left">Worldwide</phrase>
                </entry>
                <entry><phrase role="left">Recrudescence years after primary attack of louse-borne typhus</phrase>
                </entry>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. typhi</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Murine typhus</phrase>
                </entry>
                <entry><phrase role="left">Worldwide</phrase>
                </entry>
                <entry><phrase role="left">Infected flea feces rubbed into broken skin or mucous membranes or inhaled as an aerosol</phrase>
                </entry>
                <entry><phrase role="left">Rat-flea cycle; opossum-flea cycle</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Transitional group</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. akari</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Rickettsialpox</phrase>
                </entry>
                <entry><phrase role="left">North America, Ukraine, Croatia, Korea, Turkey</phrase>
                </entry>
                <entry><phrase role="left">Mite bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in mites and mite-mouse cycles</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. australis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Queensland tick typhus</phrase>
                </entry>
                <entry><phrase role="left">Australia</phrase>
                </entry>
                <entry><phrase role="left">Tick bite</phrase>
                </entry>
                <entry><phrase role="left">Ticks</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>R. felis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Flea-borne spotted fever</phrase>
                </entry>
                <entry><phrase role="left">Worldwide</phrase>
                </entry>
                <entry><phrase role="left">Not known</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in cat fleas</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Scrub typhus group</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>O. tsutsugamushi</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Scrub typhus</phrase>
                </entry>
                <entry><phrase role="left">Japan, eastern Asia, northern Australia, islands of the west and southwest Pacific and Indian Oceans</phrase>
                </entry>
                <entry><phrase role="left">Chigger bite</phrase>
                </entry>
                <entry><phrase role="left">Transovarian in mites</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para id="ch0084s0000p0014">For serologic diagnosis, blood is collected as early in the course of disease as possible, a second sample is collected after 1 or 2 weeks, and if a 4-fold rise in antibodies has not occurred, a third sample is collected 3 or 4 weeks after onset. The serum may be stored for several days at 4°C but should be stored frozen at −20°C or lower for longer periods to avoid degradation of the antibodies. However, blood samples collected by fingerstick on appropriate blotting paper in remote areas and sent by ordinary mail can be used for serologic diagnosis (<link linkend="ch0084s0000li0058">58</link>, <link linkend="ch0084s0000li0059">59</link>). Even after transport at ambient temperature, this collection method yields serologic sensitivity similar to that of testing of fresh serum for indirect immunofluorescence assay (IFA) diagnosis of scrub typhus (<link linkend="ch0084s0000li0059">59</link>).</para>
        <anchor id="ch0084s0000a0017"/>
        <beginpage pagenum="1282"/>
        <anchor id="ch0084s0000a0018"/>
        <beginpage pagenum="1283"/>
        <para id="ch0084s0000p0015">A 3-mm-diameter punch biopsy specimen of a skin lesion, preferably a maculopapule containing a petechia or the margin of an eschar, should be collected as soon as possible (<link linkend="ch0084s0000li0060">60</link>, <link linkend="ch0084s0000li0061">61</link>). Although treatment should not be delayed, it is best to perform the biopsy prior to the completion of 24 h of treatment with tetracycline or chloramphenicol. For immunohistological detection of rickettsiae, the specimen can be snap-frozen for frozen sectioning or fixed in formaldehyde for the preparation of paraffin-embedded sections (<link linkend="ch0084s0000li0028">28</link>, <link linkend="ch0084s0000li0033">33</link>, <link linkend="ch0084s0000li0060">60</link>–<link linkend="ch0084s0000li0064">64</link>). The former approach yields a result more rapidly, but freezing artifacts distort the architecture of the tissue, and fixed tissue is more convenient for shipping to a reference laboratory. Aseptically collected autopsy tissues, e.g., spleen and lung, are useful for rickettsial isolation, ideally inoculated fresh or held for 24 h at 4°C, or stored at −70°C for longer periods if the specimen must be shipped to a public health or reference laboratory. Autopsy tissues can also be examined for rickettsiae by immunohistochemistry or NAAT.</para>
      </sect2>
      <sect2 id="ch0084s0001s0006">
        <title>DIRECT DETECTION</title>
        <anchor id="ch0084s0001a0007"/>
        <anchor id="ch0084s0000a0019"/>
      </sect2>
    </sect1>
    <sect1 id="ch0084s0002">
      <title>General Considerations</title>
      <anchor id="ch0084s0002a0001"/>
      <anchor id="ch0084s0000a0020"/>
      <para id="ch0084s0000p0016">NAAT and immunohistochemical diagnostic testing, the most useful methods for establishing a diagnosis during the acute stage of illness when therapeutic decisions are critical, are available at this time, to the best of our knowledge, in only a few reference laboratories. Individual cases for immunohistochemistry may be referred to the following laboratories after the directors have been contacted for consultation: David H. Walker, Department of Pathology, University of Texas Medical Branch, 301 University Blvd., Keiller Building, Room 1.104, Galveston, TX 77555-0609 (telephone, 409-747-3990; fax, 409-747-0762; e-mail,<ulink url="mailto:dwalker@utmb.edu">dwalker@utmb.edu</ulink>); Chistopher Paddock, Rickettsial Zoonosis Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mail Stop G13, CDC, Atlanta, GA 30333 (telephone, 404-639-1309; e-mail, <ulink url="mailto:cdp9@cdc.gov">cdp9@cdc.gov</ulink>); and Gil Kersch, Rickettsial Zoonosis Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mail Stop G13, CDC, Atlanta, GA 30333 (telephone, 404-639-1082).</para>
      <sect2 id="ch0084s0002s0001">
        <title>IMMUNOLOGIC DETECTION</title>
        <anchor id="ch0084s0002a0002"/>
        <anchor id="ch0084s0000a0021"/>
        <para id="ch0084s0000p0017">The diagnoses of RMSF,<emphasis>R. parkeri</emphasis> infection, boutonneuse fever, African tick bite fever, murine typhus, louse-borne typhus, and rickettsialpox have been established by immunohistochemical detection of rickettsiae in formalin-fixed, paraffin-embedded sections of biopsy specimens of rash and eschar lesions (<link linkend="ch0084s0000li0061">61</link>–<link linkend="ch0084s0000li0064">64</link>) (<anchor id="ch0084s0000a0022"/><link linkend="ch0084s0000a0023">Fig. 2</link>, left). Monoclonal antibodies that are specific for lipopolysaccharides of either SFG or TG rickettsiae have been used to detect rickettsiae by immunohistochemical staining (<link linkend="ch0084s0000a0023">Fig. 2</link>, right). There is no commercially available antibody (<link linkend="ch0084s0000li0062">62</link>, <link linkend="ch0084s0000li0063">63</link>). The sensitivity and specificity of immunohistochemical detection of <emphasis>R. rickettsii</emphasis> in cutaneous biopsy specimens are 70% and 100%, respectively (<link linkend="ch0084s0000li0027">27</link>, <link linkend="ch0084s0000li0061">61</link>). Eschar biopsies yield sensitive specimens for the diagnosis of SFG rickettsioses that manifest such lesions and should be considered for diagnostic evaluation in patients suspected to have rickettsialpox, <emphasis>R. parkeri</emphasis> infection, boutonneuse fever, African tick bite fever, and other SFG rickettsioses. Detection of three or more rickettsiae in vascular endothelium in biopsy specimens is diagnostic of rickettsial infection. Because histologic processing results in heat denaturation of species-specific antigens, immunohistochemistry distinguishes <emphasis>Rickettsia</emphasis> only at the SFG or TG level.</para>
        <figure id="ch0084s0000f0002"><title><phrase role="figureLabel"><anchor id="ch0084s0000a0023"/><link linkend="ch0084s0000a0022">FIGURE 2</link></phrase> (Left) Direct immunofluorescence staining of skin biopsy specimens with anti-SFG <emphasis>Rickettsia</emphasis> antibodies facilitates rapid diagnosis. Rickettsiae are present in the vessel wall. (Right) Demonstration of rickettsial organisms in the microvasculature of the dermis in a patient with history of RMSF. Rickettsiae are seen in the vessel wall. Immunoperoxidase staining was done using monoclonal antibodies directed against SFG lipopolysaccharide. Skin biopsy sample magnification, ×800.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0084f02.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0084s0000p0018"><emphasis>O. tsutsugamushi</emphasis> has been identified using immunohistochemistry in human endothelial cells, dendritic cells, macrophages, and cardiac myocytes (<link linkend="ch0084s0000li0065">65</link>). Skin biopsy specimens can also be utilized for the diagnosis of scrub typhus (<link linkend="ch0084s0000li0066">66</link>). Immunohistochemical staining of maculopapular skin rash samples using a mouse polyclonal antibody against <emphasis>O. tsutsugamushi</emphasis> Boryong strain had a sensitivity of 65% with a specificity of 100%. Staining of eschar lesions with the same antibody resulted in a specificity of 100% and sensitivity of 100%. No significant loss of diagnostic effectiveness was noted in patients that had eschar biopsies tested after 3 to 4 days of antibiotic treatment.</para>
      </sect2>
      <sect2 id="ch0084s0002s0002">
        <title>MOLECULAR DETECTION</title>
        <anchor id="ch0084s0002a0003"/>
        <anchor id="ch0084s0000a0024"/>
      </sect2>
    </sect1>
    <sect1 id="ch0084s0003">
      <title>Rickettsia Species</title>
      <anchor id="ch0084s0003a0001"/>
      <anchor id="ch0084s0000a0025"/>
      <para id="ch0084s0000p0019">NAAT has been applied to the amplification of the DNA of SFG and TG rickettsiae, usually from peripheral blood, buffy coat, or plasma and occasionally from fresh, frozen, or paraffin-embedded tissue and from swabs of the ulcerated bases of eschars (<link linkend="ch0084s0000li0029">29</link>, <link linkend="ch0084s0000li0048">48</link>, <link linkend="ch0084s0000li0049">49</link>). A variety of genes have been used for the amplification of rickettsial DNA. The targets for primer design have included the 16S rRNA gene, conserved housekeeping genes such as the citrate synthase gene (<emphasis>gltA</emphasis>), antigen genes such as those encoding outer membrane proteins (<emphasis>sca0</emphasis> and <emphasis>sca5</emphasis>), and the 17-kDa-lipoprotein gene. No gene target seems more advantageous than another.</para>
      <para id="ch0084s0000p0020">Conventional, nested, and real-time PCR techniques have all been used, and there are advantages and disadvantages of each method. Conventional and nested methods offer the ability to obtain larger amplicons if sequencing for the identification of a species-specific agent is desired. Real-time PCR allows quantification, high sample throughput, reduced potential for contamination, multiplexing with a variety of species- or group-specific probes, and greater analytic sensitivity. Indeed, real-time PCR has been reported to detect fewer than 10 copies of genomic DNA per reaction (<link linkend="ch0084s0000li0067">67</link>, <link linkend="ch0084s0000li0068">68</link>). With the ability to amplify small quantities of DNA, NAAT techniques can potentially detect rickettsial organisms during the early or acute phase of disease before the generation of diagnostic antibodies. In patients treated empirically with antibiotics before diagnosis, it is slightly more sensitive (28%) than rickettsial isolation and cultivation (19%) (<link linkend="ch0084s0000li0069">69</link>). Despite the impressive analytic sensitivity of real-time PCR, it is unclear how beneficial it is when applied to clinical specimens—the sensitivity was only marginally better than that of nested NAAT performed on banked specimens (16% versus 18%) (<link linkend="ch0084s0000li0067">67</link>). A real-time reverse transcriptase assay, designed to target both 23S rDNA and rRNA from total nucleic acid, has recently been developed. With multiple copy numbers compared to pure DNA targets, the analytic sensitivity of this test appears to be 100-fold better than that of an established DNA-based real-time PCR method (<link linkend="ch0084s0000li0070">70</link>).</para>
      <anchor id="ch0084s0000a0026"/>
      <beginpage pagenum="1284"/>
      <para id="ch0084s0000p0021">The limited quantities of circulating rickettsial DNA during infection greatly hinder the clinical sensitivity of molecular detection from peripheral blood specimens. The sensitivity of genus-wide NAAT using whole-blood samples ranges from 6 to 69% in studies comparing NAAT to a serologic gold standard (<link linkend="ch0084s0000li0071">71</link>–<link linkend="ch0084s0000li0074">74</link>). A critical analysis of pooled data from this literature reports a median sensitivity of 18% (<link linkend="ch0084s0000li0075">75</link>). When rickettsial DNA is detected in blood samples, it is often in patients with severe or fatal outcomes (<link linkend="ch0084s0000li0055">55</link>, <link linkend="ch0084s0000li0056">56</link>), and when it is detected in those with RMSF, the number of copies of rickettsial DNA is greater in those who die (<link linkend="ch0084s0000li0076">76</link>). The clinical utility of NAAT is more apparent in tissue, where the sensitivity is much greater than that from peripheral blood. NAAT applied to skin biopsy specimens, particularly of eschars prior to treatment, has a sensitivity of 48 to 92% (<link linkend="ch0084s0000li0071">71</link>, <link linkend="ch0084s0000li0074">74</link>, <link linkend="ch0084s0000li0077">77</link>). Swabs are an effective and noninvasive method for the collection of rickettsial DNA from eschars for NAAT (<link linkend="ch0084s0000li0057">57</link>, <link linkend="ch0084s0000li0078">78</link>–<link linkend="ch0084s0000li0080">80</link>).</para>
      <para id="ch0084s0000p0022">A species-specific diagnosis is usually unnecessary for clinical purposes, but when the specific etiologic agent is desired for epidemiologic purposes, it can be carried out through several means. Restriction fragment length polymorphism analysis can be carried out using NAAT products using a variety of rickettsial genes and combination of restriction enzymes (<link linkend="ch0084s0000li0081">81</link>). These methods have been largely supplanted by sequencing. Probe-based real-time PCR, often multiplexed, offers the potential to differentiate infection between rickettsial groups (typhus versus spotted fever groups) or even species identification from selected agents for which targeted primers and probes are designed (<link linkend="ch0084s0000li0074">74</link>, <link linkend="ch0084s0000li0082">82</link>, <link linkend="ch0084s0000li0083">83</link>). NAATs to detect an array of organisms in addition to <emphasis>Rickettsia</emphasis> species have been developed. These multiplexed real-time assays have been designed for a variety of tick-borne pathogens (<link linkend="ch0084s0000li0084">84</link>), rickettsiae and leptospira (<link linkend="ch0084s0000li0085">85</link>), and both vasculotropic and leukocytic rickettsiae (<link linkend="ch0084s0000li0086">86</link>). Although some publications fail to differentiate between analytical versus clinical sensitivity and specificity, the latter assay was tested using human samples well characterized by rigorous diagnostic testing. The clinical sensitivities for detecting SFG and TG rickettsiae from blood were 25% and 20%, respectively. Specificity was 98% and 99% for SFG and TG rickettsiae, respectively (<link linkend="ch0084s0000li0086">86</link>).</para>
      <para id="ch0084s0000p0023">Loop-mediated isothermal amplification (LAMP) assays are practical and inexpensive and have been studied for the detection of rickettsial DNA. They have good analytical sensitivity, with lower limits of detection of 5 to 100 copies of DNA per reaction (<link linkend="ch0084s0000li0087">87</link>–<link linkend="ch0084s0000li0089">89</link>). The development of a multiplexed LAMP technique with a lateral flow dipstick-based method to detect DNA by using DNA-DNA hybridization of amplicons to complementary probes has been developed (<link linkend="ch0084s0000li0090">90</link>). This technology is intriguing for implementing field-based diagnostics where various vector-borne diseases are endemic. Recombinase polymerase amplification (RPA) assays are also attractive for development to deploy in resource-limited settings. The process takes 20 minutes, it is carried out at constant temperature (37°C), results can be visualized using a lateral-flow strip, and it has a limit of detection of 10 to 50 copies of DNA per reaction (<link linkend="ch0084s0000li0091">91</link>, <link linkend="ch0084s0000li0092">92</link>). As in the case of the aforementioned molecular methods, the paucity of circulating rickettsial organisms will likely limit the usefulness of LAMP and RPA for detection of rickettsiae from peripheral blood samples.</para>
    </sect1>
    <sect1 id="ch0084s0004">
      <title>Orientia tsutsugamushi</title>
      <anchor id="ch0084s0004a0001"/>
      <anchor id="ch0084s0000a0027"/>
      <para id="ch0084s0000p0024">NAAT for<emphasis>O. tsutsugamushi</emphasis> is typically performed on peripheral blood, buffy coat, overlying eschar crust, or tissue biopsy from an eschar. Genes often amplified include <emphasis>htrA</emphasis>, 56-kDa-protein, <emphasis>groEL</emphasis>, and the 16S rRNA gene (<link linkend="ch0084s0000li0075">75</link>). Conventional, nested, and real-time PCR have all been employed for the diagnosis of scrub typhus. The 56-kDa-protein gene is a useful target of diagnostic NAAT. A nested assay, used to amplify a 1,003-bp product followed by a 484-bp product of this <emphasis>O. tsutsugamushi</emphasis> gene, has been used with blood samples and detects 10 prototype strains (<link linkend="ch0084s0000li0048">48</link>). It is particularly useful on eschar crust, where it had an 86% sensitivity and 100% specificity in serologically confirmed cases and has good performance despite the prior use of effective antibiotics (<link linkend="ch0084s0000li0053">53</link>). Sensitivity is less when used on blood samples (81%) and diminishes after initiation of treatment (67%) (<link linkend="ch0084s0000li0093">93</link>). Considering its excellent analytical sensitivity, real-time PCR is the preferred NAAT when the equipment and technical expertise are available (<link linkend="ch0084s0000li0075">75</link>). The <emphasis>htrA</emphasis> gene is a frequently used target for real-time PCR (<link linkend="ch0084s0000li0094">94</link>) and has been applied to clinical samples (<link linkend="ch0084s0000li0093">93</link>, <link linkend="ch0084s0000li0095">95</link>), with a sensitivity of 83% when applied to buffy coat specimens of those with serologically confirmed scrub typhus (<link linkend="ch0084s0000li0095">95</link>). Amplification of a multicopy gene, <emphasis>traD</emphasis>, may improve the ability of real-time PCR to amplify smaller quantities of DNA (<link linkend="ch0084s0000li0096">96</link>). A multiplexed real-time PCR assay for the detection of numerous rickettsia-like organisms (<emphasis>Rickettsia</emphasis> spp., <emphasis>O. tsutsugamushi, E. chaffeensis</emphasis>, and <emphasis>A. phagocytophilum</emphasis>) has a sensitivity and specificity of 27% and 100%, respectively, for identifying <emphasis>O. tsutsugamushi</emphasis> (<link linkend="ch0084s0000li0086">86</link>). It should be noted that the criteria for confirmed scrub typhus were more stringent than NAAT studies comparing results with samples already known to contain detectable <emphasis>O. tsutsugamushi</emphasis> DNA. The sensitivity of this multiplex real-time PCR is comparable to singleplex real-time PCR used in some clinical settings, as documented in a study performed on the Thailand-Myanmar border, where the sensitivity of <emphasis>htrA</emphasis> real-time PCR was 29% (<link linkend="ch0084s0000li0073">73</link>). NAAT using primers designed to amplify the 56-kDa-protein gene of <emphasis>O. tsutsugamushi</emphasis> have failed to amplify “<emphasis>Candidatus</emphasis> Orientia chiloensis,” but use of primers to amplify <emphasis>htrA</emphasis>, which is more conserved, has led to successful amplification in human cases (<link linkend="ch0084s0000li0012">12</link>). Probe-based real-time PCR is also able to amplify and distinguish “<emphasis>Candidatus</emphasis> Orientia chiloensis” from <emphasis>O. tsutsugam</emphasis><emphasis>ushi</emphasis> (<link linkend="ch0084s0000li0097">97</link>).</para>
      <para id="ch0084s0000p0025">Similar to what has been developed for detection of<emphasis>Rickettsia</emphasis> species, LAMP and RPAs have been developed for the detection of <emphasis>O. tsutsugamushi</emphasis> and offer a simple method that can be used in locations lacking costly infrastructure. On clinical specimens, LAMP can detect 95% and 92% of those amplified by conventional and real-time PCR, respectively (<link linkend="ch0084s0000li0098">98</link>, <link linkend="ch0084s0000li0099">99</link>). Although of potential usefulness, when compared to more stringent diagnostic criteria (established retrospectively through a combination of molecular and serologic means), LAMP for the detection of <emphasis>O. tsutsugamushi</emphasis> has a sensitivity of up to only 56% (<link linkend="ch0084s0000li0100">100</link>). LAMP using bio-optical sensor detection (iNAD) may have improved performance; it was found that iNAD had a sensitivity and specificity of 100% and 90%, respectively, in a small cohort with scrub typhus (21 cases) (<link linkend="ch0084s0000li0101">101</link>). RPA assays for the detection of the <emphasis>htrA</emphasis> gene have been developed. Testing of samples from a limited number of scrub typhus patients by RPA demonstrated positive results in 80 to 88% of samples positive by PCR (<link linkend="ch0084s0000li0091">91</link>, <link linkend="ch0084s0000li0102">102</link>).</para>
      <anchor id="ch0084s0000a0028"/>
      <beginpage pagenum="1285"/>
    </sect1>
    <sect1 id="ch0084s0005">
      <title>Next-Generation Sequencing</title>
      <anchor id="ch0084s0005a0001"/>
      <anchor id="ch0084s0000a0029"/>
      <para id="ch0084s0000p0026">With the difficulty in detecting fastidious, deep-seated, or uncommon infecting pathogens, attention has been turned to the use of metagenomic next-generation sequencing (mNGS), where sequencing of cell-free DNA is performed to detect fragments of genomic DNA from pathogens in patient sera. These methods are intended to aid in the diagnostic approach during difficult scenarios, when routine clinical and laboratory data are unrevealing for an etiology (<link linkend="ch0084s0000li0103">103</link>). In an urban area endemic for murine typhus, mNGS using the Karius test (Karius Inc., Redwood City, CA) has helped identify <emphasis>R. typhi</emphasis> as the agent implicated in fever in 12 patients (<link linkend="ch0084s0000li0104">104</link>, <link linkend="ch0084s0000li0105">105</link>). DNA of <emphasis>O. tsutsugamushi</emphasis> has been detected in patient specimens by mNGS. In a cohort of 10 patients, mNGS enabled confirmation of a scrub typhus diagnosis in 9 cases (<link linkend="ch0084s0000li0106">106</link>), but those tested were already clinically suspected of having scrub typhus. Thus, it is unclear if mNGS would have had an impact on patient management. In Northern Thailand, <emphasis>O. tsutsugamushi</emphasis> was detected in 11 of 200 patients with undifferentiated febrile illness (<link linkend="ch0084s0000li0107">107</link>).</para>
      <para id="ch0084s0000p0027">The role of mNGS for routine pathogen detection—as well as detection of rickettsiae and<emphasis>O. tsutsugamushi</emphasis>—for clinical testing is currently undefined. Although it may be a helpful diagnostic modality in select situations, a multicenter study examining the clinical impact of mNGS for infectious diseases led to a positive clinical impact in only 7% and no impact in 87% of cases in which this technology was used (<link linkend="ch0084s0000li0108">108</link>). Cost, need for adequate controls, and need for adequate validation are issues that must be overcome for the effective use of mNGS (<link linkend="ch0084s0000li0103">103</link>).</para>
      <sect2 id="ch0084s0005s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0084s0005a0002"/>
        <anchor id="ch0084s0000a0030"/>
        <para id="ch0084s0000p0028">Due to their high infectivity at a low dose, isolation of rickettsiae and<emphasis>O. tsutsugamushi</emphasis> is performed in BSL-3 laboratories. Cumbersome historic methods, such as inoculation of guinea pigs, mice, or the yolk sacs of embryonated chicken eggs, have been supplanted by cell culture methods, except for isolation of <emphasis>O. tsutsugamushi</emphasis>, which is still sometimes achieved by intraperitoneal inoculation of mice (<link linkend="ch0084s0000li0027">27</link>, <link linkend="ch0084s0000li0047">47</link>, <link linkend="ch0084s0000li0109">109</link>). Vero, L-929, HEL, and MRC5 cells have been used in antibiotic-free media to isolate rickettsiae. The best results reported are achieved with heparin-anticoagulated plasma, buffy coat, or carefully surface-prepped, sterilely collected skin lesion biopsy specimens obtained prior to administration of antirickettsial therapy.</para>
        <para id="ch0084s0000p0029">The shell vial technique uses samples containing 0.5 ml of triturated clinical material mixed with 0.5 ml of tissue culture medium, which is inoculated as promptly as possible onto 3.7-ml shell vials with 12-mm-diameter round coverslips having a confluent layer of cells, then centrifuged at 700 ×<emphasis>g</emphasis> for 1 h at room temperature to enhance attachment and entry of rickettsiae into host cells (<link linkend="ch0084s0000li0047">47</link>). After removal of the inoculum, the shell vials are washed with phosphate-buffered saline and incubated with minimal essential medium containing 10% fetal calf serum in an atmosphere containing 5% CO<subscript>2</subscript> at 34°C. At 48 and 72 h, a coverslip is examined by Giemsa or Gimenez stain or by immunofluorescence with antibodies against SFG and TG rickettsiae. Detection of four or more organisms is interpreted as a positive result. This method has yielded a diagnosis in 59% of samples from patients with boutonneuse fever who had neither been treated nor developed antibodies to <emphasis>R. conorii</emphasis> prior to collection of the sample (<link linkend="ch0084s0000li0047">47</link>). Rickettsiae were detected at 48 h of growth in 82% of the positive samples. Incubating at lower temperatures (28°C or 32°C) may be beneficial for some suspected pathogens, specifically <emphasis>R. felis</emphasis> and <emphasis>R. massiliae</emphasis> (<link linkend="ch0084s0000li0110">110</link>, <link linkend="ch0084s0000li0111">111</link>). Earlier detection of rickettsiae is possible when the shell vial medium is tested by real-time PCR (<link linkend="ch0084s0000li0109">109</link>). Similar techniques have been applied to 24-well plates (<link linkend="ch0084s0000li0112">112</link>) or to small cell culture flasks (<link linkend="ch0084s0000li0109">109</link>). Small cell culture flasks have been used in Laos, where isolates are obtained in 26% of those with scrub typhus and 4% of those with murine typhus (confirmed by serology or NAAT). Universal precautions should be exercised, and work should be performed within a biosafety cabinet located in a BSL-3 laboratory with proper personal protective equipment. Although the quantity of rickettsiae in the cell culture is relatively low, aerosol or contact exposure should be avoided as for mycobacteria, fungi, and viruses.</para>
      </sect2>
      <sect2 id="ch0084s0005s0002">
        <title>IDENTIFICATION OF RICKETTSIA AND ORIENTIA ISOLATES</title>
        <anchor id="ch0084s0005a0003"/>
        <anchor id="ch0084s0000a0031"/>
        <para id="ch0084s0000p0030">Rickettsiae isolated in cell culture can be identified by indirect immunofluorescence with group-, species-, and strain-specific monoclonal antibodies. Rickettsial isolates are frequently identified by molecular methods such as NAAT of genes that are genus specific (17-kDa-protein gene, citrate synthase gene, or<emphasis>sca5</emphasis>) or SFG specific (<emphasis>sca0</emphasis>) (<link linkend="ch0084s0000li0077">77</link>). Alternatively, species-specific probes can be coupled with real-time PCR (<link linkend="ch0084s0000li0083">83</link>). NGS has been used to help determine the specific agent implicated in clinically suspected SFG rickettsioses in China (<link linkend="ch0084s0000li0113">113</link>, <link linkend="ch0084s0000li0114">114</link>). Determination of DNA sequences identifies unique isolates. <emphasis>O. tsutsugamushi</emphasis>, being more distantly related to <emphasis>Rickettsia</emphasis> spp., lacks the above-mentioned cell surface protein genes but can be identified by NAAT of the gene encoding the major immunodominant 56-kDa surface protein, the 47-kDa-protein gene, <emphasis>groEL</emphasis>, or the 16S rRNA gene (<link linkend="ch0084s0000li0053">53</link>, <link linkend="ch0084s0000li0075">75</link>).</para>
        <para id="ch0084s0000p0031">Historically, species identification of rickettsial isolates was performed by microimmunofluorescence serotyping. This rather cumbersome and expensive method required propagation of large quantities of the isolate and prototype strains for immunofluorescence titration and the development of typing sera by the intravenous inoculation of mice. Genetic analysis is currently favored for identification of isolates. An isolate that is known to be a<emphasis>Rickettsia</emphasis> spp. should be identified in a BSL-3 laboratory, and isolates of <emphasis>R. prowazekii</emphasis> must be handled as required by U.S. federal regulations for select agents.</para>
      </sect2>
      <sect2 id="ch0084s0005s0003">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0084s0005a0004"/>
        <anchor id="ch0084s0000a0032"/>
        <para id="ch0084s0000p0032">For most clinical microbiology laboratories, assays for antibodies to rickettsiae are the only tests, if any, performed. This situation is unfortunate for the patient with a life-threatening, acutely incapacitating rickettsial disease, because these assays are useful principally for serologic confirmation of the diagnosis in convalescence and usually do not provide information that is helpful in making critical therapeutic decisions during the acute stage of illness. Patients who die of rickettsioses usually have received many antibiotics, none of which has antirickettsial activity, owing in part to the lack of specific laboratory data providing clinical guidance for a rickettsial disease diagnosis. The earlier a diagnosis is established, the shorter the course and severity of rickettsial illness will be after an appropriate antirickettsial antibiotic is administered.</para>
        <anchor id="ch0084s0000a0033"/>
        <beginpage pagenum="1286"/>
        <para id="ch0084s0000p0033">The assays that were historically most widely used for the diagnosis of rickettsial diseases are agglutination of the OX-19 and OX-2 strains of<emphasis>Proteus vulgaris</emphasis> for TG and SFG rickettsioses and the OX-K strain of <emphasis>Proteus mirabilis</emphasis> for <emphasis>O. tsutsugamushi</emphasis> infections. These assays have poor sensitivity and specificity (<link linkend="ch0084s0000li0061">61</link>). They should be replaced by more accurate serologic methods, such as IFA or EIA. However, there are situations in developing countries where the choice is between the <emphasis>Proteus</emphasis> agglutination tests and none at all for the detection of important public health problems, such as outbreaks of louse-borne typhus (<link linkend="ch0084s0000li0115">115</link>). In fact, the evidence leading to the discoveries of Japanese spotted fever and Flinders Island spotted fever included <emphasis>Proteus</emphasis>-agglutinating antibodies.</para>
        <para id="ch0084s0000p0034">Serologic assays for the diagnosis of rickettsial infections focus on the “gold standard,” the IFA. Other approaches include indirect immunoperoxidase assay (IPA), latex agglutination, enzyme immunoassay (EIA), line blotting, Western blotting, and rapid lateral-flow assays (<link linkend="ch0084s0000li0061">61</link>, <link linkend="ch0084s0000li0116">116</link>–<link linkend="ch0084s0000li0122">122</link>). Only some of these assays are available as commercial kits or in reference laboratories, and they are not available for all rickettsial diseases. Other serologic tests, such as indirect hemagglutination, microagglutination, and complement fixation, are no longer in general use.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0084s0006">
      <title>Rickettsia Species</title>
      <anchor id="ch0084s0006a0001"/>
      <anchor id="ch0084s0000a0034"/>
      <para id="ch0084s0000p0035">The IFA contains all the rickettsial heat-labile protein antigens and group-shared lipopolysaccharide antigen and, thus, provides group-reactive serology. IFA reagents are available commercially for SFG and TG rickettsiae from BIOCELL Diagnostics (Baltimore, MD), Scimedx Corp. (Dover, NJ), Focus Diagnostics (Cypress, CA), and Fuller Laboratories (Fullerton, CA). In cases of RMSF, IFA detects antibodies at a titer of ≥64, usually in the second week of illness. Effective antirickettsial treatment of RMSF must be initiated by day 5 of illness to avoid a potentially fatal outcome. For boutonneuse fever, an IFA titer of ≥40 occurs in 46% of patients between days 5 and 9 of illness, in 90% of patients between days 20 and 29, and in 100% of patients thereafter. In murine typhus, diagnostic IFA titers are present in 50% of cases by the end of the first week of illness and in nearly all cases by 15 days after onset (<link linkend="ch0084s0000li0026">26</link>). In areas where particular rickettsial diseases are endemic, a higher diagnostic cutoff titer is required, but there is no consensus on how cutoffs are chosen (<link linkend="ch0084s0000li0123">123</link>). Each laboratory performing the test should establish its own cutoff titers for the patient population, the microscope and reagents used, and the laboratorian’s judgment of the minimal positive signal.</para>
      <para id="ch0084s0000p0036">IPA for murine typhus, boutonneuse fever, and presumably other rickettsioses yields results similar to those of IFA when the IgG diagnostic titer is set at 128 and that of IgM is set at 32 (<link linkend="ch0084s0000li0124">124</link>). Advantages include the use of a light microscope rather than a fluorescence microscope and the production of a permanent slide result. Latex agglutination test reagents are available commercially from Scimedx Corp., only for <emphasis>R. rickettsii</emphasis> in the United States. Latex beads coated with an extracted rickettsial protein-carbohydrate complex containing rickettsial lipopolysaccharide are agglutinated mainly by IgM antibodies, with reports of a sensitivity of 71 to 94% and a specificity of 96 to 99% (<link linkend="ch0084s0000li0119">119</link>). A diagnostic titer of 128 is often detected early in the second week of illness.</para>
      <para id="ch0084s0000p0037">EIAs have been developed in various formats, including antigens coating microtiter wells or immobilized on nitrocellulose or other sheets for use in the commercial reference laboratory setting. When compared with an IFA titer of ≥64 for the diagnosis of murine typhus, the dot-EIA showed a sensitivity of 88% and specificity of 91% (<link linkend="ch0084s0000li0125">125</link>). The dot-EIA for <emphasis>R. conorii</emphasis> antigen provided early diagnostic evidence of an SFG rickettsiosis. Subsequent analysis revealed poor specificity, with a high rate of false-positive results. These assays are diagnostic tools that do not require expensive, specialized equipment, but they suffer from apparent low specificity. Standard EIAs for detecting IgG or IgM antibodies against SFG and TG rickettsiae are available from Fuller Laboratories. An examination of these for the diagnosis of murine typhus performed well in a PCR-confirmed cohort when specimens were tested in both the acute and convalescent phases (<link linkend="ch0084s0000li0126">126</link>).</para>
      <para id="ch0084s0000p0038">Shared antigens of OmpA, OmpB, and group-specific lipopolysaccharide impede establishment of a species-specific diagnosis by serologic methods. The criterion of a 4-fold or greater difference in IFA titers between the two suspected agents distinguished infections by<emphasis>R. prowazekii</emphasis> and <emphasis>R. typhi</emphasis> in only 34% of cases and infections by <emphasis>R. africae</emphasis> from those by <emphasis>R. conorii</emphasis> in only 26% (<link linkend="ch0084s0000li0029">29</link>, <link linkend="ch0084s0000li0127">127</link>). Western blotting detection of antibodies against OmpA or OmpB of only one <emphasis>Rickettsia</emphasis> species has also been proposed as a criterion for species-specific diagnosis. However, it was effective in distinguishing <emphasis>R. prowazekii</emphasis> and <emphasis>R. typhi</emphasis> infections or <emphasis>R. africae</emphasis> and <emphasis>R. conorii</emphasis> infections in only one-half of the cases (<link linkend="ch0084s0000li0029">29</link>, <link linkend="ch0084s0000li0127">127</link>, <link linkend="ch0084s0000li0128">128</link>). Cumbersome, expensive cross-absorption of sera prior to IFA or Western immunoblotting is more effective in establishing a species-specific diagnosis. However, interpretation of these results requires careful evaluation of the performance of valid controls, the quality and quantity of each antigen preparation, and the potential for the occurrence of infection by an untested, even as-yet-undiscovered, agent. In the past, knowledge of the geographic origin of the case sufficed to designate the specific diagnosis. However, the increasing number and geographic overlap of rickettsioses challenge the old assumptions.</para>
    </sect1>
    <sect1 id="ch0084s0007">
      <title>Orientia tsutsugamushi</title>
      <anchor id="ch0084s0007a0001"/>
      <anchor id="ch0084s0000a0035"/>
      <para id="ch0084s0000p0039">When coupled with acute- and convalescent-phase sera, IFA continues to remain the gold standard for the diagnosis of scrub typhus (<link linkend="ch0084s0000li0075">75</link>). Reagents are available commercially from Scimedx Corp., BIOCELL Diagnostics, and Fuller Laboratories. The IFA test is not without limitations, which include cost, need for a fluorescent microscope, availability of a trained microscopist, subjectivity of interpreting endpoint titers, need for paired specimens, and consideration of cutoffs based on the regional seroprevalence. Meta-analysis of IFA serology for the diagnosis of scrub typhus led to recommendations that diagnosis be based on a 4-fold or greater rise in titer and that diagnosis not be based on a single antibody titer unless previous studies had determined the seroprevalence in the local population, justifying the cutoff titer (<link linkend="ch0084s0000li0129">129</link>). The persistence of reactive IgM for 1 year and IgG for 3 years after scrub typhus infection is problematic when single acute-phase specimens alone are considered for diagnostic purposes (<link linkend="ch0084s0000li0130">130</link>). When sera are tested only in the acute phase, the performance of IFA to reliably detect antibodies at manufacturer-suggested cutoffs is poor. An evaluation of IFA assays from various companies, using single acute-phase specimens, demonstrated the sensitivity of IgM was 56% and 64%, both with a specificity of 95%, at suggested manufacturer cutoffs of 16 and 64, respectively. The sensitivity of IgG was 42% and 67% at cutoffs of 256 and 128, respectively. Specificities of IgG at these cutoffs were 96% and 74%, respectively (<link linkend="ch0084s0000li0131">131</link>). Using the modified scrub typhus infection criteria, an admission cutoff IgM IFA titer of ≥3,200 or a &gt;4-fold rise to ≥3,200 in titers in paired convalescent-phase samples is required (<link linkend="ch0084s0000li0129">129</link>). The sensitivity and specificity of the IgM IFA are 81.6% and 100%, using the modified scrub typhus infection criteria (<link linkend="ch0084s0000li0132">132</link>). IPA for scrub typhus is comparable to IFA (<link linkend="ch0084s0000li0124">124</link>) but, other than requiring only a light microscope, has similar limitations to IFA.</para>
      <anchor id="ch0084s0000a0036"/>
      <beginpage pagenum="1287"/>
      <para id="ch0084s0000p0040">EIA has become an increasingly used method to detect antibodies reactive against<emphasis>O. tsutsugamushi.</emphasis> Its simplicity, lack of subjectivity, and reproducibility are desired attributes (<link linkend="ch0084s0000li0075">75</link>). Both whole-cell antigen and recombinant proteins (usually to the 56-kDa protein) have been used for these assays (<link linkend="ch0084s0000li0133">133</link>, <link linkend="ch0084s0000li0134">134</link>). Since remarkable diversity of <emphasis>O. tsutsugamushi</emphasis> strains is often present in a limited geographic distribution, antigens from several strains are used (<link linkend="ch0084s0000li0135">135</link>). A novel conserved <emphasis>O. tsutsugamushi</emphasis> 27-kDa protein found through immunoinformatic analysis may offer a simple and effective approach to assay design (<link linkend="ch0084s0000li0136">136</link>). As with IFA, validated cutoffs are still required. The use of Bayesian latent class modeling has allowed for determination of optimal cutoff values, aids in the ability to estimate accuracy of testing, and does not require comparison to a gold standard (<link linkend="ch0084s0000li0137">137</link>).</para>
      <para id="ch0084s0000p0041">There are currently several serology-based rapid diagnostic tests (RDTs) available. The use of lateral-flow immunochromatographic strips in these tests offers a rapid and easy-to-use diagnostic modality. Companies manufacturing these include InBios (Seattle, WA), Standard Diagnostics Inc. (Suwon, South Korea), and ImmuneMed (Seoul, South Korea). A meta-analysis examining data from studies using various RDTs revealed a pooled sensitivity of 66% and specificity of 92% (it should be noted that the methods for these studies were quite heterogenous, so care in interpreting the analysis should be considered) (<link linkend="ch0084s0000li0138">138</link>). The characteristics of RDTs on acute samples demonstrated sensitivities of 54%, 36%, and 73% with specificities of 100%, 100%, and 90% for IgM, IgG, and total immunoglobulin, respectively (<link linkend="ch0084s0000li0131">131</link>). Both studies emphasize the limitations of using single acute-phase specimens. Another study of three RDTs showed better sensitivity (87 to 92%) but lower specificity (86 to 92%) (<link linkend="ch0084s0000li0099">99</link>), likely reflecting variabilities in study design.</para>
      <sect2 id="ch0084s0007s0001">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0084s0007a0002"/>
        <anchor id="ch0084s0000a0037"/>
        <para id="ch0084s0000p0042">Data supporting the use of doxycycline or another tetracycline antibiotic as the drug of choice for the treatment of infections caused by<emphasis>Rickettsia</emphasis> spp. and the use of chloramphenicol as an alternative drug have been derived principally by observational data and a few prospective studies (<link linkend="ch0084s0000li0139">139</link>–<link linkend="ch0084s0000li0143">143</link>). Techniques to determine <emphasis>in vitro</emphasis> susceptibilities of these obligately intracellular bacteria are not standardized as they are for other bacteria. In addition to historic studies of the activity of antimicrobial agents against these obligately intracellular bacteria in infected animals and embryonated eggs, studies of the effects of antimicrobial agents in cell culture have supported the use of tetracyclines and chloramphenicol (<link linkend="ch0084s0000li0144">144</link>). <emphasis>In vitro</emphasis> studies have also supported the consideration of alternative drugs, such as fluoroquinolones, some macrolides (i.e., azithromycin and clarithromycin), and newer tetracycline-like antibiotics (i.e., eravacycline, omadacycline, and tigecycline) (<link linkend="ch0084s0000li0144">144</link>, <link linkend="ch0084s0000li0145">145</link>). Indeed, ciprofloxacin, clarithromycin, and azithromycin have been used successfully for the treatment of boutonneuse fever under certain circumstances (<link linkend="ch0084s0000li0139">139</link>, <link linkend="ch0084s0000li0141">141</link>, <link linkend="ch0084s0000li0143">143</link>), but they cannot be recommended for the most severe rickettsioses—RMSF and louse-borne epidemic typhus. A controlled trial in patients with murine typhus demonstrated that azithromycin was inferior to doxycycline based on time to defervesce and failure rate (<link linkend="ch0084s0000li0146">146</link>). Based on the time-to-defervescence criterion used by the aforementioned trial, retrospective data suggesting that ciprofloxacin is effective for murine typhus should be interpreted with caution (mean time to defervesce on ciprofloxacin was 4.2 days) (<link linkend="ch0084s0000li0140">140</link>).</para>
        <para id="ch0084s0000p0043"><emphasis>In vitro</emphasis> susceptibility does not always predict efficacy, as in the case of rifampin, where the MIC for various <emphasis>Rickettsia</emphasis> spp. ranges from 0.06 to 1.0 μg/ml (<link linkend="ch0084s0000li0144">144</link>), but clinical failures have occurred (<link linkend="ch0084s0000li0147">147</link>). Chloramphenicol has been used to treat RMSF during pregnancy, but it is difficult to procure in the United States and appears inferior to doxycycline (<link linkend="ch0084s0000li0148">148</link>). Since there are few data to support the idea that doxycycline causes harm in the developing fetus, as is the case with tetracycline hydrochloride, the benefits of doxycycline for RMSF far outweigh the risks (<link linkend="ch0084s0000li0149">149</link>). Azithromycin can be considered for less severe rickettsioses (e.g., boutonneuse fever) in pregnant women. There is little concern regarding rickettsial development of antimicrobial resistance, and antimicrobial susceptibility studies of rickettsiae are not routinely performed clinical laboratory tests (<link linkend="ch0084s0000li0150">150</link>).</para>
        <para id="ch0084s0000p0044">As with the aforementioned rickettsiae, doxycycline is the historical drug of choice for infection with<emphasis>O. tsutsugamushi</emphasis>, but chloramphenicol, azithromycin, and clarithromycin appear to be similarly effective as analyzed by systematic reviews of prospective and observational studies (<link linkend="ch0084s0000li0151">151</link>, <link linkend="ch0084s0000li0152">152</link>). Unlike the case with <emphasis>Rickettsia</emphasis> spp., rifampin is effective in those with scrub typhus (<link linkend="ch0084s0000li0152">152</link>). Azithromycin has been used successfully in cases of scrub typhus in Thailand which have not responded to doxycycline or chloramphenicol (<link linkend="ch0084s0000li0153">153</link>). The reasons for the poor performance of doxycycline in these patients are not well understood; reduced susceptibility of <emphasis>O. tsutsugamushi</emphasis> to doxycycline is controversial (<link linkend="ch0084s0000li0154">154</link>, <link linkend="ch0084s0000li0155">155</link>). In contrast, albeit based on retrospective observation and subject to bias, delayed responses to azithromycin have been reported in South India (<link linkend="ch0084s0000li0156">156</link>). It is not known if pharmacodynamic/pharmacokinetic issues, regional strain differences in antimicrobial susceptibility, or host factors play a role. <emphasis>O. tsutsugamushi</emphasis> is intrinsically resistant to fluoroquinolones (<link linkend="ch0084s0000li0157">157</link>). Research efforts to improve and streamline antibiotic testing for <emphasis>O. tsutsugamushi</emphasis> through real-time PCR show promise, but use is still limited to BSL-3 facilities (<link linkend="ch0084s0000li0158">158</link>).</para>
      </sect2>
      <sect2 id="ch0084s0007s0002">
        <title>INTERPRETATION AND REPORTING OF RESULTS</title>
        <anchor id="ch0084s0007a0003"/>
        <anchor id="ch0084s0000a0038"/>
        <para id="ch0084s0000p0045">When reporting the results of an assay for antibodies in a single serum sample, the laboratorian seldom knows the duration of illness and whether the serum sample is from the acute or the convalescent phase of the disease. For sera that are nonreactive by dot-EIA, by IFA at a dilution of 1:64, by indirect immunoperoxidase assay at a dilution of 1:128, by latex agglutination at a dilution of 1:64, or by Weil-Felix<emphasis>Proteus</emphasis> agglutination at a titer of 1:160, the laboratory report should state that no antibodies were detected at the particular cutoff dilution, which may differ among some laboratories and some patient populations; that negative results are expected in the acute stage of rickettsial illness; and that a second sample should be submitted to evaluate the possibility of seroconversion if no alternative diagnosis has been established. If paired acute- and convalescent-phase sera separated by an appropriate interval are available, they should be tested simultaneously. It is wise to test for all the rickettsial and ehrlichial agents to which the patient is likely to have been exposed in the United States. SFG rickettsiae, <emphasis>E. chaffeensis, Anaplasma phagocytophilum</emphasis>, and <emphasis>R. typhi</emphasis> are the likely agents, unless travel to an area where scrub typhus or African tick bite fever is endemic has occurred. If the paired sera fail to demonstrate a 4-fold increase in titer, the report should state that the results do not support the diagnosis of rickettsial infection but that occasionally antibody synthesis is delayed, particularly in cases with early antirickettsial therapy. If a single serum sample contains an IFA antibody titer of ≥64, an IFA IgM titer of ≥32, an indirect immunoperoxidase antibody titer of ≥128, or a latex agglutination titer of ≥64, the laboratory report should state that antibodies reactive with the particular rickettsial antigen were detected at the measured titer, that the result provides supportive evidence for the diagnosis of the rickettsial disease, and that a convalescent-phase sample should be submitted to assess the possibility of a diagnostic rise in titer.</para>
        <anchor id="ch0084s0000a0039"/>
        <beginpage pagenum="1288"/>
        <para id="ch0084s0000p0046">The reactive single serum sample is problematic. In a study of individuals from an area where RMSF is endemic, IgM seroreactivity to<emphasis>R. rickettsii</emphasis> was not predictive of a dynamic rise in subsequent IgM titers or IgG seroconversion (<link linkend="ch0084s0000li0159">159</link>). In an analysis of SFG rickettsioses in the United States, less than 1% of cases are confirmed through use of paired specimens, culture, IHC, or NAAT detection of rickettsial DNA. Of the 99% considered probable cases, 82% were based on a single antibody test and 72% were collected during the first week of illness (often a noncompatible illness), within the period of time before SFG antibodies are expected to be produced (<link linkend="ch0084s0000li0160">160</link>). If paired sera measured simultaneously show a 4-fold or greater rise in titer, the interpretation is that the results strongly support the rickettsial diagnosis indicated by the tested antigen. If a significant titer is detected in the acute-phase sample, but no rise or only a single doubling dilution rise was measured, it should be stated that an additional later sample should be tested to evaluate a 4-fold rise or fall in titer. The concept that recrudescent typhus could be distinguished from primary louse-borne typhus by the absence of IgM antibodies to <emphasis>R. prowazekii</emphasis> and of <emphasis>Proteus</emphasis> OX-19-agglutinating antibodies has been challenged (<link linkend="ch0084s0000li0118">118</link>). The manufacturers of the dot-EIA have recommended the interpretation that strongly reactive samples (three or four dots) may indicate the presence of a specific antibody response and that weakly reactive samples (one or two dots) are infrequent but possible in normal populations. Retesting 2 to 3 weeks later would establish the diagnosis if three or four dots develop in the convalescent-phase serology and should always be performed. It is important to understand that healthy persons can have serum antibodies reactive with SFG rickettsiae. The seroprevalence in healthy blood donors in the state of Georgia, an area of SFG rickettsiosis endemicity, is 11%, and in Oregon, an area presumed to have fewer SFG rickettsioses, the seroprevalence is 6% (<link linkend="ch0084s0000li0161">161</link>). It is also important to understand that patients with Rocky Mountain spotted fever generally do not develop antibodies to <emphasis>R. rickettsii</emphasis> during the first week of illness. Thus, antibodies detected earlier than this time likely preexist the febrile illness.</para>
        <para id="ch0084s0000p0047">Isolation of a rickettsia from blood or tissue may be interpreted as indicating an etiologic role. The level of identification of the isolate should be stated, whether identified only as SFG or TG or to the species level.</para>
        <para id="ch0084s0000p0048">Immunohistological diagnostic interpretation states the method, reactivity of the method (e.g., antibody reactive with SFG rickettsiae), and location of the antigen (e.g., in vascular endothelium and frequently adjacent vascular smooth muscle for<emphasis>R. rickettsii</emphasis>).</para>
        <para id="ch0084s0000p0049">Interpretation of NAAT results should state the target gene, the organisms that would be detected, and the presence or absence of a nucleic acid product. If a specific oligonucleotide probe or DNA sequencing confirmed the specificity of the identification, this result should be stated. For negative immunohistological and NAAT results, it should always be stated that the failure to detect the agent does not exclude the diagnosis, along with data regarding the sensitivity and specificity of the assay in the particular laboratory, if known, and the effects of antirickettsial treatment on the sensitivity.</para>
        <para id="ch0084s0000p0050">Special efforts should be made, in coordination with the CDC, to establish the diagnosis of fatal cases, which include performing rickettsial isolation, immunohistology, NAAT, and serology on samples collected at necropsy.</para>
      </sect2>
      <sect2 id="ch0084s0007s0003">
        <title>REFERENCES</title>
        <anchor id="ch0084s0007a0004"/>
        <anchor id="ch0084s0000a0040"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0084s0000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Yu X-J, Walker DH.</emphasis> 2005. Family I. Rickettsiaceae, p 96–114. <citetitle><emphasis>In</emphasis></citetitle> Brenner DJ, Kreig NR, Stanley JT (ed), <citetitle><emphasis>Bergey’s Manual of Systematic Bacteriology</emphasis></citetitle>, 2nd ed, vol 2. Springer, New York, NY.</para>
          </listitem>
          <listitem id="ch0084s0000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Fournier PE, Dumler JS, Greub G, Zhang J, Wu Y, Raoult D.</emphasis> 2003. Gene sequence-based criteria for identification of new rickettsia isolates and description of <citetitle><emphasis>Rickettsia heilongjiangensis</emphasis></citetitle> sp. nov. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>5456–5465.</para>
          </listitem>
          <listitem id="ch0084s0000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Gevers D, Cohan FM, Lawrence JG, Spratt BG, Coenye T, Feil EJ, Stackebrandt E, Van de Peer Y, Vandamme P, Thompson FL, Swings J.</emphasis> 2005. Opinion: re-evaluating prokaryotic species. <citetitle><emphasis>Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">3:</emphasis>733–739.</para>
          </listitem>
          <listitem id="ch0084s0000li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Weinert LA, Werren JH, Aebi A, Stone GN, Jiggins FM.</emphasis> 2009. Evolution and diversity of Rickettsia bacteria. <citetitle><emphasis>BMC Biol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>6.</para>
          </listitem>
          <listitem id="ch0084s0000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Parola P, Paddock CD, Socolovschi C, Labruna MB, Mediannikov O, Kernif T, Abdad MY, Stenos J, Bitam I, Fournier PE, Raoult D.</emphasis> 2013. Update on tick-borne rickettsioses around the world: a geographic approach. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">26:</emphasis>657–702.</para>
          </listitem>
          <listitem id="ch0084s0000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Gillespie JJ, Williams K, Shukla M, Snyder EE, Nordberg EK, Ceraul SM, Dharmanolla C, Rainey D, Soneja J, Shallom JM, Vishnubhat ND, Wattam R, Purkayastha A, Czar M, Crasta O, Setubal JC, Azad AF, Sobral BS.</emphasis> 2008. Rickettsia phylogenomics: unwinding the intricacies of obligate intracellular life. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">3:</emphasis>e2018.</para>
          </listitem>
          <listitem id="ch0084s0000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Lee JH, Park HS, Jang WJ, Koh SE, Kim JM, Shim SK, Park MY, Kim YW, Kim BJ, Kook YH, Park KH, Lee SH.</emphasis> 2003. Differentiation of rickettsiae by <citetitle><emphasis>groEL</emphasis></citetitle> gene analysis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>2952–2960.</para>
          </listitem>
          <listitem id="ch0084s0000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Vitorino L, Chelo IM, Bacellar F, Zé-Zé L.</emphasis> 2007. Rickettsiae phylogeny: a multigenic approach. <citetitle><emphasis>Microbiol Read</emphasis></citetitle> <emphasis role="strong">153:</emphasis>160–168.</para>
          </listitem>
          <listitem id="ch0084s0000li0009" role="bibliographyEntry">
            <anchor id="ch0084s0000a0041"/>
            <para>9.<emphasis role="strong">Kelly DJ, Fuerst PA, Ching WM, Richards AL.</emphasis> 2009. Scrub typhus: the geographic distribution of phenotypic and genotypic variants of <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle>. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">48</emphasis>(Suppl 3)<emphasis role="strong">:</emphasis>S203–S230.</para>
          </listitem>
          <listitem id="ch0084s0000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Izzard L, Fuller A, Blacksell SD, Paris DH, Richards AL, Aukkanit N, Nguyen C, Jiang J, Fenwick S, Day NP, Graves S, Stenos J.</emphasis> 2010. Isolation of a novel <citetitle><emphasis>Orientia</emphasis></citetitle> species (<citetitle><emphasis>O. chuto</emphasis></citetitle> spp. nov.) from a patient infected in Dubai. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>4404–4409.</para>
          </listitem>
          <listitem id="ch0084s0000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Jiang J, Paris DH, Blacksell SD, Aukkanit N, Newton PN, Phetsouvanh R, Izzard L, Stenos J, Graves SR, Day NP, Richards AL.</emphasis> 2013. Diversity of the 47-kD HtrA nucleic acid and translated amino acid sequences from 17 recent human isolates of Orientia. <citetitle><emphasis>Vector Borne Zoonotic Dis</emphasis></citetitle> <emphasis role="strong">13:</emphasis>367–375.</para>
          </listitem>
          <listitem id="ch0084s0000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Abarca K, Martínez-Valdebenito C, Angulo J, Jiang J, Farris CM, Richards AL, Acosta-Jamett G, Weitzel T.</emphasis> 2020. Molecular description of a novel <citetitle><emphasis>Orientia</emphasis></citetitle> species causing scrub typhus in Chile. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">26:</emphasis>2148–2156.</para>
          </listitem>
          <listitem id="ch0084s0000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Cosson JF, Galan M, Bard E, Razzauti M, Bernard M, Morand S, Brouat C, Dalecky A, Bâ K, Charbonnel N, Vayssier-Taussat M.</emphasis> 2015. Detection of Orientia spp. DNA in rodents from Asia, West Africa and Europe. <citetitle><emphasis>Parasit Vectors</emphasis></citetitle> <emphasis role="strong">8:</emphasis>172.</para>
          </listitem>
          <listitem id="ch0084s0000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Gilmore RD Jr.</emphasis> 1993. Comparison of the rompA gene repeat regions of Rickettsiae reveals species-specific arrangements of individual repeating units. <citetitle><emphasis>Gene</emphasis></citetitle> <emphasis role="strong">125:</emphasis>97–102.</para>
          </listitem>
          <listitem id="ch0084s0000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">McLeod MP, Qin X, Karpathy SE, Gioia J, Highlander SK, Fox GE, McNeill TZ, Jiang H, Muzny D, Jacob LS, Hawes AC, Sodergren E, Gill R, Hume J, Morgan M, Fan G, Amin AG, Gibbs RA, Hong C, Yu XJ, Walker DH, Weinstock GM.</emphasis> 2004. Complete genome sequence of <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> and comparison with sequences of other rickettsiae. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">186:</emphasis>5842–5855.</para>
          </listitem>
          <listitem id="ch0084s0000li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Sahni A, Patel J, Narra HP, Schroeder CLC, Walker DH, Sahni SK.</emphasis> 2017. Fibroblast growth factor receptor-1 mediates internalization of pathogenic spotted fever rickettsiae into host endothelium. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">12</emphasis><emphasis role="strong">:</emphasis>e0183181.</para>
          </listitem>
          <listitem id="ch0084s0000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Martinez JJ, Seveau S, Veiga E, Matsuyama S, Cossart P.</emphasis> 2005. Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. <citetitle><emphasis>Cell</emphasis></citetitle> <emphasis role="strong">123:</emphasis>1013–1023.</para>
          </listitem>
          <listitem id="ch0084s0000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Martinez JJ, Cossart P.</emphasis> 2004. Early signaling events involved in the entry of Rickettsia conorii into mammalian cells. <citetitle><emphasis>J Cell Sci</emphasis></citetitle> <emphasis role="strong">117:</emphasis>5097–5106.</para>
          </listitem>
          <listitem id="ch0084s0000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Whitworth T, Popov VL, Yu XJ, Walker DH, Bouyer DH.</emphasis> 2005. Expression of the <citetitle><emphasis>Rickettsia prowazekii pld</emphasis></citetitle> or <citetitle><emphasis>tlyC</emphasis></citetitle> gene in <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovar Typhimurium mediates phagosomal escape. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">73:</emphasis>6668–6673.</para>
          </listitem>
          <listitem id="ch0084s0000li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Cho NH, Kim HR, Lee JH, Kim SY, Kim J, Cha S, Kim SY, Darby AC, Fuxelius HH, Yin J, Kim JH, Kim J, Lee SJ, Koh YS, Jang WJ, Park KH, Andersson SG, Choi MS, Kim IS.</emphasis> 2007. The Orientia tsutsugamushi genome reveals massive proliferation of conjugative type IV secretion system and host-cell interaction genes. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">104:</emphasis>7981–7986.</para>
          </listitem>
          <listitem id="ch0084s0000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Horta MC, Moraes-Filho J, Casagrande RA, Saito TB, Rosa SC, Ogrzewalska M, Matushima ER, Labruna MB.</emphasis> 2009. Experimental infection of opossums Didelphis aurita by Rickettsia rickettsii and evaluation of the transmission of the infection to ticks Amblyomma cajennense. <citetitle><emphasis>Vector Borne Zoonotic Dis</emphasis></citetitle> <emphasis role="strong">9:</emphasis>109–118.</para>
          </listitem>
          <listitem id="ch0084s0000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Labruna MB, Ogrzewalska M, Martins TF, Pinter A, Horta MC.</emphasis> 2008. Comparative susceptibility of larval stages of Amblyomma aureolatum, Amblyomma cajennense, and Rhipicephalus sanguineus to infection by Rickettsia rickettsii. <citetitle><emphasis>J Med Entomol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1156–1159.</para>
          </listitem>
          <listitem id="ch0084s0000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">McDade JE, Shepard CC, Redus MA, Newhouse VF, Smith JD.</emphasis> 1980. Evidence of Rickettsia prowazekii infections in the United States. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">29:</emphasis>277–284.</para>
          </listitem>
          <listitem id="ch0084s0000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Souza CE, Moraes-Filho J, Ogrzewalska M, Uchoa FC, Horta MC, Souza SS, Borba RC, Labruna MB.</emphasis> 2009. Experimental infection of capybaras Hydrochoerus hydrochaeris by Rickettsia rickettsii and evaluation of the transmission of the infection to ticks Amblyomma cajennense. <citetitle><emphasis>Vet Parasitol</emphasis></citetitle> <emphasis role="strong">161:</emphasis>116–121.</para>
          </listitem>
          <listitem id="ch0084s0000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS.</emphasis> 2016. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis—United States. <citetitle><emphasis>MMWR Recomm Re</emphasis></citetitle><citetitle><emphasis>p</emphasis></citetitle> <emphasis role="strong">65:</emphasis>1–44.</para>
          </listitem>
          <listitem id="ch0084s0000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Dumler JS, Taylor JP, Walker DH.</emphasis> 1991. Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. <citetitle><emphasis>JAMA</emphasis></citetitle> <emphasis role="strong">266:</emphasis>1365–1370.</para>
          </listitem>
          <listitem id="ch0084s0000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Kaplowitz LG, Lange JV, Fischer JJ, Walker DH.</emphasis> 1983. Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. <citetitle><emphasis>Arch Intern Med</emphasis></citetitle> <emphasis role="strong">143:</emphasis>1149–1151.</para>
          </listitem>
          <listitem id="ch0084s0000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Kass EM, Szaniawski WK, Levy H, Leach J, Srinivasan K, Rives C.</emphasis> 1994. Rickettsialpox in a New York City hospital, 1980 to 1989. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">331:</emphasis>1612–1617.</para>
          </listitem>
          <listitem id="ch0084s0000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Raoult D, Fournier PE, Fenollar F, Jensenius M, Prioe T, de Pina JJ, Caruso G, Jones N, Laferl H, Rosenblatt JE, Marrie TJ.</emphasis> 2001. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">344:</emphasis>1504–1510.</para>
          </listitem>
          <listitem id="ch0084s0000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Padgett KA, Bonilla D, Eremeeva ME, Glaser C, Lane RS, Porse CC, Castro MB, Messenger S, Espinosa A, Hacker J, Kjemtrup A, Ryan B, Scott JJ, Hu R, Yoshimizu MH, Dasch GA, Kramer V.</emphasis> 2016. The eco-epidemiology of Pacific Coast tick fever in California. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">10</emphasis><emphasis role="strong">:</emphasis>e0005020.</para>
          </listitem>
          <listitem id="ch0084s0000li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, von Sonnenburg F, Loutan L, Leder K, Freedman DO, GeoSentinel Surveillance Network.</emphasis> 2013. Acute and potentially life-threatening tropical diseases in western travelers—a GeoSentinel multicenter study, 1996-2011. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">88:</emphasis>397–404.</para>
          </listitem>
          <listitem id="ch0084s0000li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">de Sousa R, Ismail N, Dória-Nóbrega S, Costa P, Abreu T, França A, Amaro M, Proença P, Brito P, Poças J, Ramos T, Cristina G, Pombo G, Vitorino L, Torgal J, Bacellar F, Walker D.</emphasis> 2005. The presence of eschars, but not greater severity, in Portuguese patients infected with Israeli spotted fever. <citetitle><emphasis>Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">1063:</emphasis>197–202.</para>
          </listitem>
          <listitem id="ch0084s0000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Walker DH, Crawford CG, Cain BG.</emphasis> 1980. Rickettsial infection of the pulmonary microcirculation: the basis for interstitial pneumonitis in Rocky Mountain spotted fever. <citetitle><emphasis>Hum Pathol</emphasis></citetitle> <emphasis role="strong">11:</emphasis>263–272.</para>
          </listitem>
          <listitem id="ch0084s0000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Bradshaw MJ, Byrge KC, Ivey KS, Pruthi S, Bloch KC.</emphasis> 2020. Meningoencephalitis due to spotted fever rickettsioses, including Rocky Mountain spotted fever. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">71:</emphasis>188–195.</para>
          </listitem>
          <listitem id="ch0084s0000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Horney LF, Walker DH.</emphasis> 1988. Meningoencephalitis as a major manifestation of Rocky Mountain spotted fever. <citetitle><emphasis>South Med J</emphasis></citetitle> <emphasis role="strong">81:</emphasis>915–918.</para>
          </listitem>
          <listitem id="ch0084s0000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, Lane CC, Ekenna O, Blass MA, Tamminga CL, Ohl CA, McLellan SL, Goddard J, Holman RC, Openshaw JJ, Sumner JW, Zaki SR, Eremeeva ME.</emphasis> 2008. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">47:</emphasis>1188–1196.</para>
          </listitem>
          <listitem id="ch0084s0000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Blanton LS, Walker DH.</emphasis> 2017. Flea-borne rickettsioses and rickettsiae. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">96:</emphasis>53–56.</para>
          </listitem>
          <listitem id="ch0084s0000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Parola P.</emphasis> 2011. Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">17</emphasis><emphasis role="strong">:</emphasis>996–1000.</para>
          </listitem>
          <listitem id="ch0084s0000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Billeter SA, Metzger ME.</emphasis> 2017. Limited evidence for <citetitle><emphasis>Rickettsia felis</emphasis></citetitle> as a cause of zoonotic flea-borne rickettsiosis in Southern California. <citetitle><emphasis>J Med Entomol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>4–7.</para>
          </listitem>
          <listitem id="ch0084s0000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Tsioutis C, Zafeiri M, Avramopoulos A, Prousali E, Miligkos M, Karageorgos SA.</emphasis> 2017. Clinical and laboratory characteristics, epidemiology, and outcomes of murine typhus: a systematic review. <citetitle><emphasis>Acta Trop</emphasis></citetitle> <emphasis role="strong">166:</emphasis>16–24.</para>
          </listitem>
          <listitem id="ch0084s0000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Doppler JF, Newton PN.</emphasis> 2020. A systematic review of the untreated mortality of murine typhus. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">14</emphasis><emphasis role="strong">:</emphasis>e0008641.</para>
          </listitem>
          <listitem id="ch0084s0000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Walker DH.</emphasis> 2003. Principles of the malicious use of infectious agents to create terror: reasons for concern for organisms of the genus Rickettsia. <citetitle><emphasis>Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">990:</emphasis>739–742.</para>
          </listitem>
          <listitem id="ch0084s0000li0043" role="bibliographyEntry">
            <anchor id="ch0084s0000a0042"/>
            <para>43.<emphasis role="strong">Paris DH.</emphasis> 2020. <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> (scrub typhus), p 2377–2381. <citetitle><emphasis>In</emphasis></citetitle> Bennett JE, Dolin R, Blaser MJ (ed), <citetitle><emphasis>Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases</emphasis></citetitle>, 9th ed, vol 2. Elsevier, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0084s0000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Kim DM, Yun NR, Neupane GP, Shin SH, Ryu SY, Yoon HJ, Wie SH, Kim WJ, Lee CY, Choi JS, Yang TY.</emphasis> 2011. Differences in clinical features according to Boryoung and Karp genotypes of <citetitle><emphasis>Orientia tsutsugamushi. PLoS One</emphasis></citetitle> <emphasis role="strong">6:</emphasis>e22731.</para>
          </listitem>
          <listitem id="ch0084s0000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Bonell A, Lubell Y, Newton PN, Crump JA, Paris DH.</emphasis> 2017. Estimating the burden of scrub typhus: a systematic review. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">11</emphasis><emphasis role="strong">:</emphasis>e0005838.</para>
          </listitem>
          <listitem id="ch0084s0000li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Weitzel T, Martínez-Valdebenito C, Acosta-Jamett G, Jiang J, Richards AL, Abarca K.</emphasis> 2019. Scrub typhus in continental Chile, 2016-2018. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">25:</emphasis>1214–1217.</para>
          </listitem>
          <listitem id="ch0084s0000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">La Scola B, Raoult D.</emphasis> 1996. Diagnosis of Mediterranean spotted fever by cultivation of <citetitle><emphasis>Rickettsia conorii</emphasis></citetitle> from blood and skin samples using the centrifugation-shell vial technique and by detection of <citetitle><emphasis>R. conorii</emphasis></citetitle> in circulating endothelial cells: a 6-year follow-up. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>2722–2727.</para>
          </listitem>
          <listitem id="ch0084s0000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Saisongkorh W, Chenchittikul M, Silpapojakul K.</emphasis> 2004. Evaluation of nested PCR for the diagnosis of scrub typhus among patients with acute pyrexia of unknown origin. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">98:</emphasis>360–366.</para>
          </listitem>
          <listitem id="ch0084s0000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Schriefer ME, Sacci JB Jr, Dumler JS, Bullen MG, Azad AF.</emphasis> 1994. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>949–954.</para>
          </listitem>
          <listitem id="ch0084s0000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Sonthayanon P, Chierakul W, Wuthiekanun V, Phimda K, Pukrittayakamee S, Day NP, Peacock SJ.</emphasis> 2009. Association of high <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> DNA loads with disease of greater severity in adults with scrub typhus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>430–434.</para>
          </listitem>
          <listitem id="ch0084s0000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Zavala-Castro JE, Dzul-Rosado KR, León JJ, Walker DH, Zavala-Velázquez JE.</emphasis> 2008. An increase in human cases of spotted fever rickettsiosis in Yucatan, Mexico, involving children. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">79:</emphasis>907–910.</para>
          </listitem>
          <listitem id="ch0084s0000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Boudebouch N, Sarih M, Socolovschi C, Fatihi T, Chakib A, Amarouch H, Hassar M, Rolain JM, Parola P, Raoult D.</emphasis> 2009. Spotted fever group rickettsioses documented in Morocco. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">15</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>257–258.</para>
          </listitem>
          <listitem id="ch0084s0000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Kim DM, Kim HL, Park CY, Yang TY, Lee JH, Yang JT, Shim SK, Lee SH.</emphasis> 2006. Clinical usefulness of eschar polymerase chain reaction for the diagnosis of scrub typhus: a prospective study. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">43:</emphasis>1296–1300.</para>
          </listitem>
          <listitem id="ch0084s0000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Mouffok N, Parola P, Lepidi H, Raoult D.</emphasis> 2009. Mediterranean spotted fever in Algeria—new trends. <citetitle><emphasis>Int J Infect Dis</emphasis></citetitle> <emphasis role="strong">13:</emphasis>227–235.</para>
          </listitem>
          <listitem id="ch0084s0000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Leitner M, Yitzhaki S, Rzotkiewicz S, Keysary A.</emphasis> 2002. Polymerase chain reaction-based diagnosis of Mediterranean spotted fever in serum and tissue samples. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">67:</emphasis>166–169.</para>
          </listitem>
          <listitem id="ch0084s0000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Mendes do Nascimento EM, Colombo S, Nagasse-Sugahara TK, Angerami RN, Resende MR, da Silva LJ, Katz G, dos Santos FC.</emphasis> 2009. Evaluation of PCR-based assay in human serum samples for diagnosis of fatal cases of spotted fever group rickettsiosis. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">15</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>232–234.</para>
          </listitem>
          <listitem id="ch0084s0000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Bechah Y, Socolovschi C, Raoult D.</emphasis> 2011. Identification of rickettsial infections by using cutaneous swab specimens and PCR. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>83–86.</para>
          </listitem>
          <listitem id="ch0084s0000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Fenollar F, Raoult D.</emphasis> 1999. Diagnosis of rickettsial diseases using samples dried on blotting paper. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>483–488.</para>
          </listitem>
          <listitem id="ch0084s0000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Phetsouvanh R, Blacksell SD, Jenjaroen K, Day NP, Newton PN.</emphasis> 2009. Comparison of indirect immunofluorescence assays for diagnosis of scrub typhus and murine typhus using venous blood and finger prick filter paper blood spots. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">80:</emphasis>837–840.</para>
          </listitem>
          <listitem id="ch0084s0000li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Montenegro MR, Mansueto S, Hegarty BC, Walker DH.</emphasis> 1983. The histology of “taches noires” of boutonneuse fever and demonstration of Rickettsia conorii in them by immunofluorescence. <citetitle><emphasis>Virchows Arch A Pathol Anat Histopathol</emphasis></citetitle> <emphasis role="strong">400:</emphasis>309–317.</para>
          </listitem>
          <listitem id="ch0084s0000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Walker DH, Burday MS, Folds JD.</emphasis> 1980. Laboratory diagnosis of Rocky Mountain spotted fever. <citetitle><emphasis>South Med J</emphasis></citetitle> <emphasis role="strong">73:</emphasis>1443–1446, 1449.</para>
          </listitem>
          <listitem id="ch0084s0000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Walker DH, Feng HM, Ladner S, Billings AN, Zaki SR, Wear DJ, Hightower B.</emphasis> 1997. Immunohistochemical diagnosis of typhus rickettsioses using an anti-lipopolysaccharide monoclonal antibody. <citetitle><emphasis>Mod Pathol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>1038–1042.</para>
          </listitem>
          <listitem id="ch0084s0000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Walker DH, Hudnall SD, Szaniawski WK, Feng HM.</emphasis> 1999. Monoclonal antibody-based immunohistochemical diagnosis of rickettsialpox: the macrophage is the principal target. <citetitle><emphasis>Mod Pathol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>529–533.</para>
          </listitem>
          <listitem id="ch0084s0000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Walker DH, Parks FM, Betz TG, Taylor JP, Muehlberger JW.</emphasis> 1989. Histopathology and immunohistologic demonstration of the distribution of Rickettsia typhi in fatal murine typhus. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">91:</emphasis>720–724.</para>
          </listitem>
          <listitem id="ch0084s0000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Moron CG, Popov VL, Feng HM, Wear D, Walker DH.</emphasis> 2001. Identification of the target cells of Orientia tsutsugamushi in human cases of scrub typhus. <citetitle><emphasis>Mod Pathol</emphasis></citetitle> <emphasis role="strong">14:</emphasis>752–759.</para>
          </listitem>
          <listitem id="ch0084s0000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Kim DM, Park CJ, Lim SC, Park KH, Jang WJ, Lee SH.</emphasis> 2008. Diagnosis of scrub typhus by immunohistochemical staining of Orientia tsutsugamushi in cutaneous lesions. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">130:</emphasis>543–551.</para>
          </listitem>
          <listitem id="ch0084s0000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Kato CY, Chung IH, Robinson LK, Austin AL, Dasch GA, Massung RF.</emphasis> 2013. Assessment of real-time PCR assay for detection of <citetitle><emphasis>Rickettsia</emphasis></citetitle> spp. and <citetitle><emphasis>Rickettsia rickettsii</emphasis></citetitle> in banked clinical samples. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>314–317.</para>
          </listitem>
          <listitem id="ch0084s0000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Prakash JA, Reller ME, Barat N, Dumler JS.</emphasis> 2009. Assessment of a quantitative multiplex 5′ nuclease real-time PCR for spotted fever and typhus group rickettsioses and Orientia tsutsugamushi. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">15</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>292–293.</para>
          </listitem>
          <listitem id="ch0084s0000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Angelakis E, Richet H, Rolain JM, La Scola B, Raoult D.</emphasis> 2012. Comparison of real-time quantitative PCR and culture for the diagnosis of emerging Rickettsioses. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">6:</emphasis>e1540.</para>
          </listitem>
          <listitem id="ch0084s0000li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Chung IH, Robinson LK, Stewart-Juba JJ, Dasch GA, Kato CY.</emphasis> 2022. Analytically sensitive <citetitle><emphasis>Rickettsia</emphasis></citetitle> species detection for laboratory diagnosis. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">106:</emphasis>tpmd210757.</para>
          </listitem>
          <listitem id="ch0084s0000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Kurokawa I, Kondo M, Akachi S.</emphasis> 2013. Early diagnosis of Japan spotted fever by PCR using skin samples. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">19:</emphasis>628–632.</para>
          </listitem>
          <listitem id="ch0084s0000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Kondo M, Akachi S, Kawano M, Yamanaka K, Yamagiwa A, Gabazza EC, Ando K, Mizutani H.</emphasis> 2015. Improvement in early diagnosis of Japanese spotted fever by using a novel Rick PCR system. <citetitle><emphasis>J Dermatol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>1066–1071.</para>
          </listitem>
          <listitem id="ch0084s0000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Watthanaworawit W, Turner P, Turner C, Tanganuchitcharnchai A, Richards AL, Bourzac KM, Blacksell SD, Nosten F.</emphasis> 2013. A prospective evaluation of real-time PCR assays for the detection of Orientia tsutsugamushi and Rickettsia spp. for early diagnosis of rickettsial infections during the acute phase of undifferentiated febrile illness. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">89:</emphasis>308–310.</para>
          </listitem>
          <listitem id="ch0084s0000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Znazen A, Sellami H, Elleuch E, Hattab Z, Ben Sassi L, Khrouf F, Dammak H, Letaief A, Ben Jemaa M, Hammami A.</emphasis> 2015. Comparison of two quantitative real time PCR assays for Rickettsia detection in patients from Tunisia. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">9</emphasis><emphasis role="strong">:</emphasis>e0003487.</para>
          </listitem>
          <listitem id="ch0084s0000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Paris DH, Dumler JS.</emphasis> 2016. State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. <citetitle><emphasis>Curr Opin Infect Dis</emphasis></citetitle> <emphasis role="strong">29:</emphasis>433–439.</para>
          </listitem>
          <listitem id="ch0084s0000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Kato C, Chung I, Paddock C.</emphasis> 2016. Estimation of Rickettsia rickettsii copy number in the blood of patients with Rocky Mountain spotted fever suggests cyclic diurnal trends in bacteraemia. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">22:</emphasis>394–396.</para>
          </listitem>
          <listitem id="ch0084s0000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Fournier PE, Raoult D.</emphasis> 2004. Suicide PCR on skin biopsy specimens for diagnosis of rickettsioses. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>3428–3434.</para>
          </listitem>
          <listitem id="ch0084s0000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Wang JM, Hudson BJ, Watts MR, Karagiannis T, Fisher NJ, Anderson C, Roffey P.</emphasis> 2009. Diagnosis of Queensland tick typhus and African tick bite fever by PCR of lesion swabs. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>963–965.</para>
          </listitem>
          <listitem id="ch0084s0000li0079" role="bibliographyEntry">
            <anchor id="ch0084s0000a0043"/>
            <para>79.<emphasis role="strong">Socolovschi C, Renvoisé A, Brouqui P, Parola P, Raoult D.</emphasis> 2012. The use of eschar swabs for the diagnosis of African tick-bite fever. <citetitle><emphasis>Ticks Tick Borne Dis</emphasis></citetitle> <emphasis role="strong">3:</emphasis>361–363.</para>
          </listitem>
          <listitem id="ch0084s0000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Myers T, Lalani T, Dent M, Jiang J, Daly PL, Maguire JD, Richards AL.</emphasis> 2013. Detecting Rickettsia parkeri infection from eschar swab specimens. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>778–780.</para>
          </listitem>
          <listitem id="ch0084s0000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Peniche-Lara G, Zavala-Velazquez J, Dzul-Rosado K, Walker DH, Zavala-Castro J.</emphasis> 2013. Simple method to differentiate among Rickettsia species. <citetitle><emphasis>J Mol Microbiol Biotechnol</emphasis></citetitle> <emphasis role="strong">23:</emphasis>203–208.</para>
          </listitem>
          <listitem id="ch0084s0000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Denison AM, Amin BD, Nicholson WL, Paddock CD.</emphasis> 2014. Detection of Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari in skin biopsy specimens using a multiplex real-time polymerase chain reaction assay. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">59:</emphasis>635–642.</para>
          </listitem>
          <listitem id="ch0084s0000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Paris DH, Blacksell SD, Stenos J, Graves SR, Unsworth NB, Phetsouvanh R, Newton PN, Day NP.</emphasis> 2008. Real-time multiplex PCR assay for detection and differentiation of rickettsiae and orientiae. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">102:</emphasis>186–193.</para>
          </listitem>
          <listitem id="ch0084s0000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Buchan BW, Jobe DA, Mashock M, Gerstbrein D, Faron ML, Ledeboer NA, Callister SM.</emphasis> 2019. Evaluation of a novel multiplex high-definition PCR assay for detection of tick-borne pathogens in whole-blood specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>e00513–19.</para>
          </listitem>
          <listitem id="ch0084s0000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Sea-Liang N, Sereemaspun A, Patarakul K, Gaywee J, Rodkvamtook W, Srisawat N, Wacharaplusadee S, Hemachudha T.</emphasis> 2019. Development of multiplex PCR for neglected infectious diseases. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">13</emphasis><emphasis role="strong">:</emphasis>e0007440.</para>
          </listitem>
          <listitem id="ch0084s0000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Reller ME, Dumler JS.</emphasis> 2020. Optimization and evaluation of a multiplex quantitative PCR assay for detection of nucleic acids in human blood samples from patients with spotted fever rickettsiosis, typhus rickettsiosis, scrub typhus, monocytic ehrlichiosis, and granulocytic anaplasmosis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>e01802–19.</para>
          </listitem>
          <listitem id="ch0084s0000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Pan L, Zhang L, Wang G, Liu Q.</emphasis> 2012. Rapid, simple, and sensitive detection of the ompB gene of spotted fever group rickettsiae by loop-mediated isothermal amplification. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">12:</emphasis>254.</para>
          </listitem>
          <listitem id="ch0084s0000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Hanaoka N, Matsutani M, Satoh M, Ogawa M, Shirai M, Ando S.</emphasis> 2017. Development of a novel loop-mediated isothermal amplification (LAMP) assay for the detection of Rickettsia spp. <citetitle><emphasis>Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">70:</emphasis>119–123.</para>
          </listitem>
          <listitem id="ch0084s0000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Dittrich S, Castonguay-Vanier J, Moore CE, Thongyoo N, Newton PN, Paris DH.</emphasis> 2014. Loop-mediated isothermal amplification for <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> (the causal agent of murine typhus): problems with diagnosis at the limit of detection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>832–838.</para>
          </listitem>
          <listitem id="ch0084s0000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Moonga LC, Hayashida K, Kawai N, Nakao R, Sugimoto C, Namangala B, Yamagishi J.</emphasis> 2020. Development of a multiplex loop-mediated isothermal amplification (LAMP) method for simultaneous detection of spotted fever group rickettsiae and malaria parasites by dipstick DNA chromatography. <citetitle><emphasis>Diagnostics (Basel)</emphasis></citetitle> <emphasis role="strong">10:</emphasis>897.</para>
          </listitem>
          <listitem id="ch0084s0000li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Chao CC, Belinskaya T, Zhang Z, Ching WM.</emphasis> 2015. Development of recombinase polymerase amplification assays for detection of Orientia tsutsugamushi or Rickettsia typhi. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">9</emphasis><emphasis role="strong">:</emphasis>e0003884.</para>
          </listitem>
          <listitem id="ch0084s0000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Qi Y, Shao Y, Rao J, Shen W, Yin Q, Li X, Chen H, Li J, Zeng W, Zheng S, Liu S, Li Y.</emphasis> 2018. Development of a rapid and visual detection method for <citetitle><emphasis>Rickettsia rickettsii</emphasis></citetitle> combining recombinase polymerase assay with lateral flow test. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">13</emphasis><emphasis role="strong">:</emphasis>e0207811.</para>
          </listitem>
          <listitem id="ch0084s0000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Yun NR, Kim CM, Kim DY, Seo JW, Kim DM.</emphasis> 2021. Clinical usefulness of 16S ribosomal RNA real-time PCR for the diagnosis of scrub typhus. <citetitle><emphasis>Sci Rep</emphasis></citetitle> <emphasis role="strong">11:</emphasis>14299.</para>
          </listitem>
          <listitem id="ch0084s0000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Jiang J, Chan TC, Temenak JJ, Dasch GA, Ching WM, Richards AL.</emphasis> 2004. Development of a quantitative real-time polymerase chain reaction assay specific for Orientia tsutsugamushi. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">70:</emphasis>351–356.</para>
          </listitem>
          <listitem id="ch0084s0000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Kim DM, Park G, Kim HS, Lee JY, Neupane GP, Graves S, Stenos J.</emphasis> 2011. Comparison of conventional, nested, and real-time quantitative PCR for diagnosis of scrub typhus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>607–612.</para>
          </listitem>
          <listitem id="ch0084s0000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Chao CC, Belinskaya T, Zhang Z, Jiang L, Ching WM.</emphasis> 2019. Assessment of a sensitive qPCR assay targeting a multiple-copy gene to detect <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> DNA. <citetitle><emphasis>Trop Med Infect Dis</emphasis></citetitle> <emphasis role="strong">4:</emphasis>113.</para>
          </listitem>
          <listitem id="ch0084s0000li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Jiang J, Martínez-Valdebenito C, Weitzel T, Farris CM, Acosta-Jamett G, Abarca K, Richards AL.</emphasis> 2022. Development of a new genus-specfific quantitative real-time PCR assay for the diagnosis of scrub typhus in South America. <citetitle><emphasis>Front Med (Lausanne)</emphasis></citetitle> <emphasis role="strong">9:</emphasis>831045.</para>
          </listitem>
          <listitem id="ch0084s0000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Karthikeyan PA, Hoti SL, Kanungo R.</emphasis> 2019. Evaluation of loop-mediated isothermal amplification assay for detection of scrub typhus in patients with acute febrile illness presenting to a Tertiary Care Center in Puducherry, India. <citetitle><emphasis>J Lab Physicians</emphasis></citetitle> <emphasis role="strong">11:</emphasis>82–86.</para>
          </listitem>
          <listitem id="ch0084s0000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Kannan K, John R, Kundu D, Dayanand D, Abhilash KPP, Mathuram AJ, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Gunasekaran K, Iyadurai R, Abraham AM, Prakash JAJ, Yesudhason BL, Veeraraghavan B, Kavitha ML, Jose LR, Sumana MN, Saravu K, Varghese GM.</emphasis> 2020. Performance of molecular and serologic tests for the diagnosis of scrub typhus. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">14</emphasis><emphasis role="strong">:</emphasis>e0008747.</para>
          </listitem>
          <listitem id="ch0084s0000li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Paris DH, Blacksell SD, Newton PN, Day NP.</emphasis> 2008. Simple, rapid and sensitive detection of Orientia tsutsugamushi by loop-isothermal DNA amplification. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">102:</emphasis>1239–1246.</para>
          </listitem>
          <listitem id="ch0084s0000li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Kim JY, Koo B, Jin CE, Kim MC, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Shin Y, Kim SH.</emphasis> 2018. Rapid diagnosis of tick-borne illnesses by use of one-step isothermal nucleic acid amplification and bio-optical sensor detection. <citetitle><emphasis>Clin Chem</emphasis></citetitle> <emphasis role="strong">64:</emphasis>556–565.</para>
          </listitem>
          <listitem id="ch0084s0000li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Nguyen CT, Nguyen UD, Le TT, Bui HT, Nguyen ANT, Thi Nguyen AN, Trieu NT, Trieu LP, Bui ST, Nguyen C, Van Hoang L, Ho SA, Van Nguyen B, Stenman J, Ho TH.</emphasis> 2020. Establishment of recombinase polymerase amplification assay for rapid and sensitive detection of <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> in Southeast Asia. <citetitle><emphasis>Acta Trop</emphasis></citetitle> <emphasis role="strong">210:</emphasis>105541.</para>
          </listitem>
          <listitem id="ch0084s0000li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Blauwkamp TA, Thair S, Rosen MJ, Blair L, Lindner MS, Vilfan ID, Kawli T, Christians FC, Venkatasubrahmanyam S, Wall GD, Cheung A, Rogers ZN, Meshulam-Simon G, Huijse L, Balakrishnan S, Quinn JV, Hollemon D, Hong DK, Vaughn ML, Kertesz M, Bercovici S, Wilber JC, Yang S.</emphasis> 2019. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. <citetitle><emphasis>Nat Microbiol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>663–674.</para>
          </listitem>
          <listitem id="ch0084s0000li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Stafford IA, Centeno FH, Al Mohajer M, Parkerson G, Woc-Colburn L, Burgos-Lee AJ, Rac M, Dunn J, Muldrew K.</emphasis> 2020. Successful detection of unrecognized <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> in pregnancy using cell-free next-generation sequencing. <citetitle><emphasis>Case Rep Obstet Gynecol</emphasis></citetitle> <emphasis role="strong">2020:</emphasis>6767351.</para>
          </listitem>
          <listitem id="ch0084s0000li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Centeno FH, Lasco T, Ahmed AA, Al Mohajer M.</emphasis> 2021. Characteristics of <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> infections detected with next-generation sequencing of microbial cell-free deoxyribonucleic acid in a tertiary care hospital. <citetitle><emphasis>Open Forum Infect Dis</emphasis></citetitle> <emphasis role="strong">8:</emphasis>ofab147.</para>
          </listitem>
          <listitem id="ch0084s0000li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Liu X, Zhang Y, Zhang J, Lou Z, Xia H, Lu Z.</emphasis> 2021. The early diagnosis of scrub typhus by metagenomic next-generation sequencing. <citetitle><emphasis>Front Public Health</emphasis></citetitle> <emphasis role="strong">9:</emphasis>755228.</para>
          </listitem>
          <listitem id="ch0084s0000li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Takhampunya R, Korkusol A, Pongpichit C, Yodin K, Rungrojn A, Chanarat N, Promsathaporn S, Monkanna T, Thaloengsok S, Tippayachai B, Kumfao N, Richards AL, Davidson SA.</emphasis> 2019. Metagenomic approach to characterizing disease epidemiology in a disease-endemic environment in northern Thailand. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>319.</para>
          </listitem>
          <listitem id="ch0084s0000li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Hogan CA, Yang S, Garner OB, Green DA, Gomez CA, Dien Bard J, Pinsky BA, Banaei N.</emphasis> 2021. Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">72:</emphasis>239–245.</para>
          </listitem>
          <listitem id="ch0084s0000li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Ming DK, Phommadeechack V, Panyanivong P, Sengdatka D, Phuklia W, Chansamouth V, Roberts T, Blacksell SD, Newton PN, Robinson MT.</emphasis> 2020. The isolation of <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> and <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> from human blood through mammalian cell culture: a descriptive series of 3,227 samples and outcomes in the Lao People’s Democratic Republic. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>e01553–20.</para>
          </listitem>
          <listitem id="ch0084s0000li0110" role="bibliographyEntry">
            <anchor id="ch0084s0000a0044"/>
            <para>110.<emphasis role="strong">Segura F, Pons I, Sanfeliu I, Nogueras MM.</emphasis> 2016. Shell-vial culture, coupled with real-time PCR, applied to Rickettsia conorii and Rickettsia massiliae-Bar29 detection, improving the diagnosis of the Mediterranean spotted fever. <citetitle><emphasis>Ticks Tick Borne Dis</emphasis></citetitle> <emphasis role="strong">7:</emphasis>457–461.</para>
          </listitem>
          <listitem id="ch0084s0000li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Segura F, Pons I, Pla J, Nogueras MM.</emphasis> 2015. Shell-vial culture and real-time PCR applied to Rickettsia typhi and Rickettsia felis detection. <citetitle><emphasis>World J Microbiol Biotechnol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>1747–1754.</para>
          </listitem>
          <listitem id="ch0084s0000li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Zavala-Castro JE, Dzul-Rosado KR, Peniche-Lara G, Tello-Martín R, Zavala-Velázquez JE.</emphasis> 2014. Isolation of <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> from human, Mexico. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>1411–1412.</para>
          </listitem>
          <listitem id="ch0084s0000li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Teng Z, Shi Y, Peng Y, Zhang H, Luo X, Lun X, Xia L, You Y, Li Z, Zhang W, Zhang Y, Dong S, Guo W, Kan B, Pang B, Xu J, Qin A.</emphasis> 2021. Severe case of rickettsiosis identified by metagenomic sequencing, China. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1530–1532.</para>
          </listitem>
          <listitem id="ch0084s0000li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Xu N, Gai W, Zhang Y, Wang W, Wang G, Dasch GA, Eremeeva ME.</emphasis> 2021. Confirmation of <citetitle><emphasis>Rickettsia conorii</emphasis></citetitle> subspecies indica infection by next-generation sequencing, Shandong, China. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>2691–2694.</para>
          </listitem>
          <listitem id="ch0084s0000li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Animut A, Mekonnen Y, Shimelis D, Ephraim E.</emphasis> 2009. Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. <citetitle><emphasis>Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">62:</emphasis>107–110.</para>
          </listitem>
          <listitem id="ch0084s0000li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Ching WM, Rowland D, Zhang Z, Bourgeois AL, Kelly D, Dasch GA, Devine PL.</emphasis> 2001. Early diagnosis of scrub typhus with a rapid flow assay using recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>409–414.</para>
          </listitem>
          <listitem id="ch0084s0000li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Coleman RE, Sangkasuwan V, Suwanabun N, Eamsila C, Mungviriya S, Devine P, Richards AL, Rowland D, Ching WM, Sattabongkot J, Lerdthusnee K.</emphasis> 2002. Comparative evaluation of selected diagnostic assays for the detection of IgG and IgM antibody to Orientia tsutsugamushi in Thailand. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">67:</emphasis>497–503.</para>
          </listitem>
          <listitem id="ch0084s0000li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Eremeeva ME, Balayeva NM, Raoult D.</emphasis> 1994. Serological response of patients suffering from primary and recrudescent typhus: comparison of complement fixation reaction, Weil-Felix test, microimmunofluorescence, and immunoblotting. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">1:</emphasis>318–324.</para>
          </listitem>
          <listitem id="ch0084s0000li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Hechemy KE, Anacker RL, Philip RN, Kleeman KT, MacCormack JN, Sasowski SJ, Michaelson EE.</emphasis> 1980. Detection of Rocky Mountain spotted fever antibodies by a latex agglutination test. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>144–150.</para>
          </listitem>
          <listitem id="ch0084s0000li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Jang WJ, Huh MS, Park KH, Choi MS, Kim IS.</emphasis> 2003. Evaluation of an immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Orientia tsutsugamushi infection. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>394–398.</para>
          </listitem>
          <listitem id="ch0084s0000li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Jiang J, Marienau KJ, May LA, Beecham HJ III, Wilkinson R, Ching WM, Richards AL.</emphasis> 2003. Laboratory diagnosis of two scrub typhus outbreaks at Camp Fuji, Japan in 2000 and 2001 by enzyme-linked immunosorbent assay, rapid flow assay, and Western blot assay using outer membrane 56-kD recombinant proteins. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">69:</emphasis>60–66.</para>
          </listitem>
          <listitem id="ch0084s0000li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Wilkinson R, Rowland D, Ching WM.</emphasis> 2003. Development of an improved rapid lateral flow assay for the detection of Orientia tsutsugamushi-specific IgG/IgM antibodies. <citetitle><emphasis>Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">990:</emphasis>386–390.</para>
          </listitem>
          <listitem id="ch0084s0000li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Dhawan S, Robinson MT, Stenos J, Graves SR, Wangrangsimakul T, Newton PN, Day NPJ, Blacksell SD.</emphasis> 2020. Selection of diagnostic cutoffs for murine typhus IgM and IgG immunofluorescence assay: a systematic review. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">103:</emphasis>55–63.</para>
          </listitem>
          <listitem id="ch0084s0000li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Kelly DJ, Wong PW, Gan E, Lewis GE Jr.</emphasis> 1988. Comparative evaluation of the indirect immunoperoxidase test for the serodiagnosis of rickettsial disease. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">38:</emphasis>400–406.</para>
          </listitem>
          <listitem id="ch0084s0000li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Kelly DJ, Chan CT, Paxton H, Thompson K, Howard R, Dasch GA.</emphasis> 1995. Comparative evaluation of a commercial enzyme immunoassay for the detection of human antibody to Rickettsia typhi. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">2:</emphasis>356–360.</para>
          </listitem>
          <listitem id="ch0084s0000li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Lokida D, Sudarmono P, Kosasih H, Butar-Butar DP, Salim G, Antonjaya U, Sari RA, Aman AT, Parwati I, Arif M, Lau CY, Karyana M.</emphasis> 2020. Comparison of commercial enzyme-linked immunosorbent assay and immunofluorescence assay for diagnosis of acute <citetitle><emphasis>Rickettsia typhi</emphasis></citetitle> infections. <citetitle><emphasis>Vector Borne Zoonotic Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>93–99.</para>
          </listitem>
          <listitem id="ch0084s0000li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Jensenius M, Fournier PE, Vene S, Ringertz SH, Myrvang B, Raoult D.</emphasis> 2004. Comparison of immunofluorescence, Western blotting, and cross-adsorption assays for diagnosis of African tick bite fever. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">11:</emphasis>786–788.</para>
          </listitem>
          <listitem id="ch0084s0000li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">La Scola B, Rydkina L, Ndihokubwayo JB, Vene S, Raoult D.</emphasis> 2000. Serological differentiation of murine typhus and epidemic typhus using cross-adsorption and Western blotting. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>612–616.</para>
          </listitem>
          <listitem id="ch0084s0000li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP.</emphasis> 2007. Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">44:</emphasis>391–401.</para>
          </listitem>
          <listitem id="ch0084s0000li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Varghese GM, Rajagopal VM, Trowbridge P, Purushothaman D, Martin SJ.</emphasis> 2018. Kinetics of IgM and IgG antibodies after scrub typhus infection and the clinical implications. <citetitle><emphasis>Int J Infect Dis</emphasis></citetitle> <emphasis role="strong">71:</emphasis>53–55.</para>
          </listitem>
          <listitem id="ch0084s0000li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Kim CM, Kim DM, Yun NR.</emphasis> 2021. Evaluation of the diagnostic accuracy of antibody assays for patients with scrub typhus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">59</emphasis><emphasis role="strong">:</emphasis>e0294220.</para>
          </listitem>
          <listitem id="ch0084s0000li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Lim C, Blacksell SD, Laongnualpanich A, Kantipong P, Day NP, Paris DH, Limmathurotsakul D.</emphasis> 2015. Optimal cutoff titers for indirect immunofluorescence assay for diagnosis of scrub typhus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>3663–3666.</para>
          </listitem>
          <listitem id="ch0084s0000li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Ogawa M, Satoh M, Saijo M, Ando S.</emphasis> 2017. Evaluation of a broad-ranging and convenient enzyme-linked immunosorbent assay using the lysate of infected cells with five serotypes of Orientia tsutsugamushi, a causative agent of scrub typhus. <citetitle><emphasis>BMC Microbiol</emphasis></citetitle> <emphasis role="strong">17:</emphasis>7.</para>
          </listitem>
          <listitem id="ch0084s0000li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Chao CC, Zhang Z, Belinskaya T, Thipmontree W, Tantibhedyangkul W, Silpasakorn S, Wongsawat E, Suputtamongkol Y, Ching WM.</emphasis> 2017. An ELISA assay using a combination of recombinant proteins from multiple strains of Orientia tsutsugamushi offers an accurate diagnosis for scrub typhus. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>413.</para>
          </listitem>
          <listitem id="ch0084s0000li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Yang SL, Tsai KH, Chen HF, Luo JY, Shu PY.</emphasis> 2019. Evaluation of enzyme-linked immunosorbent assay using recombinant 56-kDa type-specific antigens derived from multiple <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> strains for detection of scrub typhus infection. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">100:</emphasis>532–539.</para>
          </listitem>
          <listitem id="ch0084s0000li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Kim W, Lee SY, Kim SI, Sohng IK, Park SC, Jun S, Lee CS, Kim HY, Park EC.</emphasis> 2021. Identification of a novel antigen for serological diagnosis of scrub typhus. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">105:</emphasis>1356–1361.</para>
          </listitem>
          <listitem id="ch0084s0000li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Blacksell SD, Lim C, Tanganuchitcharnchai A, Jintaworn S, Kantipong P, Richards AL, Paris DH, Limmathurotsakul D, Day NPJ.</emphasis> 2016. Optimal cutoff and accuracy of an IgM enzyme-linked immunosorbent assay for diagnosis of acute scrub typhus in northern Thailand: an alternative reference method to the IgM immunofluorescence assay. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>1472–1478.</para>
          </listitem>
          <listitem id="ch0084s0000li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Saraswati K, Day NPJ, Mukaka M, Blacksell SD.</emphasis> 2018. Scrub typhus point-of-care testing: a systematic review and meta-analysis. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">12</emphasis><emphasis role="strong">:</emphasis>e0006330.</para>
          </listitem>
          <listitem id="ch0084s0000li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Cascio A, Colomba C, Di Rosa D, Salsa L, di Martino L, Titone L.</emphasis> 2001. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">33:</emphasis>409–411.</para>
          </listitem>
          <listitem id="ch0084s0000li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Gikas A, Doukakis S, Pediaditis J, Kastanakis S, Psaroulaki A, Tselentis Y.</emphasis> 2002. Murine typhus in Greece: epidemiological, clinical, and therapeutic data from 83 cases. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">96:</emphasis>250–253.</para>
          </listitem>
          <listitem id="ch0084s0000li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Meloni G, Meloni T.</emphasis> 1996. Azithromycin vs. doxycycline for Mediterranean spotted fever. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">15:</emphasis>1042–1044.</para>
          </listitem>
          <listitem id="ch0084s0000li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Dumler JS.</emphasis> 2012. Clinical disease: current treatment and new challenges, p 1–39. <citetitle><emphasis>In</emphasis></citetitle> Palmer GH, Azad AF (ed), <citetitle><emphasis>Intracellular Pathogens II: Rickettsiales.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0084s0000li0143" role="bibliographyEntry">
            <anchor id="ch0084s0000a0045"/>
            <para>143.<emphasis role="strong">Ruiz Beltrán R, Herrero Herrero JI.</emphasis> 1992. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">11:</emphasis>427–431.</para>
          </listitem>
          <listitem id="ch0084s0000li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Rolain JM, Maurin M, Vestris G, Raoult D.</emphasis> 1998. In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">42:</emphasis>1537–1541.</para>
          </listitem>
          <listitem id="ch0084s0000li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">Quade BR, Ramírez-Hernández A, Blanton LS.</emphasis> 2021. <citetitle><emphasis>In vitro</emphasis></citetitle> susceptibility of <citetitle><emphasis>Rickettsia</emphasis></citetitle> species to eravacycline, omadacycline, and tigecycline. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">65</emphasis><emphasis role="strong">:</emphasis>e0066521.</para>
          </listitem>
          <listitem id="ch0084s0000li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Newton PN, Keolouangkhot V, Lee SJ, Choumlivong K, Sisouphone S, Choumlivong K, Vongsouvath M, Mayxay M, Chansamouth V, Davong V, Phommasone K, Sirisouk J, Blacksell SD, Nawtaisong P, Moore CE, Castonguay-Vanier J, Dittrich S, Rattanavong S, Chang K, Darasavath C, Rattanavong O, Paris DH, Phetsouvanh R.</emphasis> 2019. A prospective, open-label, randomized trial of doxycycline versus azithromycin for the treatment of uncomplicated murine typhus. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">68:</emphasis>738–747.</para>
          </listitem>
          <listitem id="ch0084s0000li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Bella F, Espejo E, Uriz S, Serrano JA, Alegre MD, Tort J.</emphasis> 1991. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">164:</emphasis>433–434.</para>
          </listitem>
          <listitem id="ch0084s0000li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE.</emphasis> 2001. Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">184:</emphasis>1437–1444.</para>
          </listitem>
          <listitem id="ch0084s0000li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Cross R, Ling C, Day NP, McGready R, Paris DH.</emphasis> 2016. Revisiting doxycycline in pregnancy and early childhood—time to rebuild its reputation? <citetitle><emphasis>Expert Opin Drug Saf</emphasis></citetitle> <emphasis role="strong">15:</emphasis>367–382.</para>
          </listitem>
          <listitem id="ch0084s0000li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Vanrompay D, Nguyen TLA, Cutler SJ, Butaye P.</emphasis> 2018. Antimicrobial resistance in <citetitle><emphasis>Chlamydiales</emphasis></citetitle>, <citetitle><emphasis>Rickettsia</emphasis></citetitle>, <citetitle><emphasis>Coxiella</emphasis></citetitle>, and other intracellular pathogens. <citetitle><emphasis>Microbiol Spectr</emphasis></citetitle> <emphasis role="strong">6:</emphasis>6.2.15.</para>
          </listitem>
          <listitem id="ch0084s0000li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">El Sayed I, Liu Q, Wee I, Hine P.</emphasis> 2018. Antibiotics for treating scrub typhus. <citetitle><emphasis>Cochrane Database Syst Rev</emphasis></citetitle> <emphasis role="strong">9</emphasis><emphasis role="strong">:</emphasis>CD002150.</para>
          </listitem>
          <listitem id="ch0084s0000li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Yang J, Luo L, Chen T, Li L, Xu X, Zhang Y, Cao W, Yue P, Bao F, Liu A.</emphasis> 2020. Efficacy and safety of antibiotics for treatment of scrub typhus: a network meta-analysis. <citetitle><emphasis>JAMA Netw Open</emphasis></citetitle> <emphasis role="strong">3</emphasis><emphasis role="strong">:</emphasis>e2014487.</para>
          </listitem>
          <listitem id="ch0084s0000li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Watt G, Chouriyagune C, Ruangweerayud R, Watcharapichat P, Phulsuksombati D, Jongsakul K, Teja-Isavadharm P, Bhodhidatta D, Corcoran KD, Dasch GA, Strickman D.</emphasis> 1996. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. <citetitle><emphasis>Lancet</emphasis></citetitle> <emphasis role="strong">348:</emphasis>86–89.</para>
          </listitem>
          <listitem id="ch0084s0000li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Wangrangsimakul T, Phuklia W, Newton PN, Richards AL, Day NPJ.</emphasis> 2020. Scrub typhus and the misconception of doxycycline resistance. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">70:</emphasis>2444–2449.</para>
          </listitem>
          <listitem id="ch0084s0000li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Watt G.</emphasis> 2020. Drug-resistant scrub typhus. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">71:</emphasis>1580.</para>
          </listitem>
          <listitem id="ch0084s0000li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Veerappan I, Ramar R, Palanisamy S.</emphasis> 2021. Antibiotic response to pediatric scrub typhus in South India: is clinical failure to azithromycin to be worried? <citetitle><emphasis>J Trop Pediatr</emphasis></citetitle> <emphasis role="strong">67:</emphasis>fmab013.</para>
          </listitem>
          <listitem id="ch0084s0000li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Jang HC, Choi SM, Jang MO, Ahn JH, Kim UJ, Kang SJ, Shin JH, Choy HE, Jung SI, Park KH.</emphasis> 2013. Inappropriateness of quinolone in scrub typhus treatment due to gyrA mutation in Orientia tsutsugamushi Boryong strain. <citetitle><emphasis>J Korean Med Sci</emphasis></citetitle> <emphasis role="strong">28:</emphasis>667–671.</para>
          </listitem>
          <listitem id="ch0084s0000li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Phuklia W, Panyanivong P, Sengdetka D, Sonthayanon P, Newton PN, Paris DH, Day NPJ, Dittrich S.</emphasis> 2019. Novel high-throughput screening method using quantitative PCR to determine the antimicrobial susceptibility of <citetitle><emphasis>Orientia tsutsugamushi</emphasis></citetitle> clinical isolates. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">74:</emphasis>74–81.</para>
          </listitem>
          <listitem id="ch0084s0000li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">McQuiston JH, Wiedeman C, Singleton J, Carpenter LR, McElroy K, Mosites E, Chung I, Kato C, Morris K, Moncayo AC, Porter S, Dunn J.</emphasis> 2014. Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain spotted fever. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">91:</emphasis>767–770.</para>
          </listitem>
          <listitem id="ch0084s0000li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Binder AM, Nichols Heitman K, Drexler NA.</emphasis> 2019. Diagnostic methods used to classify confirmed and probable cases of spotted fever rickettsioses—United States, 2010–2015. <citetitle><emphasis>MMWR Morb Mortal Wkly Rep</emphasis></citetitle> <emphasis role="strong">68:</emphasis>243–246.</para>
          </listitem>
          <listitem id="ch0084s0000li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Straily A, Stuck S, Singleton J, Brennan S, Marcum S, Condit M, Lee C, Kato C, Tonnetti L, Stramer SL, Paddock CD.</emphasis> 2020. Antibody titers reactive with <citetitle><emphasis>Rickettsia rickettsii</emphasis></citetitle> in blood donors and implications for surveillance of spotted fever rickettsiosis in the United States. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">221:</emphasis>1371–1378.</para>
          </listitem>
        </itemizedlist>
      </sect2>
    </sect1>
  </chapter>
